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Summary !
Infection of cattle with the tick-borne apicomplexan parasite Theileria parva results in the 
fatal lympho-proliferative disease known as East Coast fever (ECF). ECF is considered to be 
one of the most devastating diseases of livestock in sub-Saharan Africa affecting all sectors 
of livestock production. The three-host brown ear tick, Rhipicephalus appendiculatus is the 
primary vector of T. parva with all tick life stages adapted to feeding on cattle. Currently, there 
is no effective vaccine against ECF and control of R. appendiculatus and T. parva occurs 
primarily through the use of disease tolerant breeds, chemotherapy and acaricide application. 
Widespread application of acaricides for tick and tick borne-disease control is becoming less 
viable due to rapid development of acaricide resistance.  In addition concerns regarding 
environment and product contamination due to long-term persistence of acaricide residues 
and high costs associated with infrastructure maintenance exist. Alternative measures for tick 
control based on integrated and sustainable methods are urgently needed.  
Control of the one host tick Rhipicephalus microplus through anti-tick vaccination has been 
shown to be viable culminating in the commercial products Gavac™ and TickGard™.  Both 
vaccines are based on the recombinant protein Bm86 expressed as concealed antigen in the 
R. microplus midgut. Vaccination elicits humoral immune response targeting Bm86 during tick 
feeding resulting in extensive gut damage. In this thesis, anti-tick vaccines were evaluated for 
their ability to control R. appendiculatus tick populations and to interfere with transmission of 
T. parva in their natural host-pathogen-vector system.  
The R. appendiculatus homologue of Bm86, named Ra86, was examined for of its impact 
on nymphal and adult R. appendiculatus ticks after feeding on Ra86 vaccinated cattle. The 
molting success of nymphal ticks to the adult stage was significantly reduced in ticks feeding 
on Ra86 vaccinated animals in comparison control animals. Simulations based on our 
empirical data suggest that repeated Ra86 vaccinations would reduce tick populations over 
successive generations. This experiment showed for the first time that Ra86 based 
vaccination could play a part in integrated pest management and control strategies for R. 
appendiculatus. Reducing the nymphal population molting to adult instars has implications for 
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ECF clinical disease severity. T. parva transmission by adult ticks is commonly associated 
with more severe ECF disease symptoms when compared to nymph mediated transmission. 
Reduction of the number of adult ticks before they can transmit T. parva may lead to 
diminution of the negative impact of ECF on animal productivity. Additionally, Ra86 
vaccination lowered T. parva infection levels in ticks that fed on vaccinated cattle indicating 
that targeting the tick gut could affect the uptake of T. parva from infected cattle and/or further 
development within the vector. 
Vaccines that block parasite transmission either to- or from- the vertebrate host have been 
proposed for the control of numerous vector-borne diseases including ECF. Cattle were 
vaccinated with a multivalent recombinant antigen cocktail containing R. appendiculatus 
antigens TRP64, histamine binding protein (male and female variants) and subolesin. 
Included in this cocktail was the T. parva protein p67, located on the sporozoite surface. 
Transmission of T. parva sporozoites from infected ticks to the vaccinated cattle was 
compared to control cattle. Establishment of ECF was 20 % lower in the vaccinated animals 
indicating that this multivalent vaccine partially prevented disease establishment. Importantly, 
animals that showed no or only mild ECF symptoms after cocktail vaccination and infected 
tick exposure were solidly protected from lethal needle challenge with the homologous T. 
parva stock. This work demonstrated for the first time that transmission of T. parva can be 
reduced by vaccination resulting in lowering of ECF clinical cases while still advantageously 
enables establishment of immune protection.  
Current experimental infection of animals with T. parva involves the needle administration 
of cryo-preserved isolated sporozoites. This highly artificial infection method differs from 
natural tick based T. parva infection in both the delivery route and the number of parasite 
injected over time. A reliable tick-based infection method for ECF resembling natural field 
situations is essential for future intervention studies. Here we show for the first time that the 
R. appendiculatus RAM-L tick line is a suitable tool that reproducibly delivers T. parva 
infectious sporozoite doses to cattle resembling endemically stable field situations. Our newly 
developed RAM-L tick based infection model can provide information on the potential 
protective capacity of experimental subunit T. parva vaccines requiring substantially smaller 
animal numbers than conventional field trials. Additionally, combination vaccines targeting 
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both tick-vector as well as the parasite can now be evaluated. 
At the recent Seventh International Conference on Ticks and Tick-Borne Pathogens, 2011, 
in Zaragoza, Spain, over half of the presentations given in the vaccine session focused on 
anti-tick vaccination. While historically the main focus of anti-tick vaccination has been on the 
control of the R. microplus, the application of similar approaches to other tick species is being 
pursued. This work adds novel information on anti-tick and transmission blocking vaccine 
testing for control of R. appendiculatus and T. parva. !!
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Abbreviations !
ATV Anti-tick vaccine 
CTL Cytotoxic T lymphocytes 
ECF East Coast fever 
ELISA Enzyme linked immunosorbant assay 
ILRI International Livestock Research Institute 
IPM Integrated pest management 
ITM Infection and treatment method 
PBMC Peripheral blood mononuclear cells  
PCR Polymerase Chain Reaction 
RAM-L Rhipicephalus appendiculatus Muguga Low Line 
RNAi RNA interference 
SDS-PAGE Sodium dodecyl sulphate polyacrylamide gel electrophoresis 
SwissTPH Swiss Tropical and Public Health Institute 
TCGF T cell growth factor 
TBV Transmission blocking vaccine 
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History of East Coast fever 
East Coast fever (ECF) is a tick-borne disease caused by the apicomplexan parasite 
Theileria parva. “ECF has undoubtedly had more impact on the development of the beef and 
dairy cattle industries, on veterinary infrastructure, legislation and policies, and on veterinary 
research in Africa than any other livestock disease complex” (quote from P.J. McCoster, 
1991). 
ECF was first described officially in 1902 after the importation of cattle into southern 
Africa from East Africa to restock cattle herds after a devastating rinderpest epidemic. ECF is 
a major disease of cattle in 11 countries in eastern, central and southern Africa. Affected 
countries are Burundi, Kenya, Malawi, Mozambique, Rwanda, Sudan, Tanzania, Uganda, 
Zaire, Zambia and Zimbabwe. (Brown et al., 1990; Norval et al., 1992). The relatively high 
cost of treatment coupled with poor veterinary services available, especially to smallholder 
farmers, imply that only a small proportion of infected animals have access to proper 
treatment.  Considerable economic losses are caused by ECF with annual estimates of US$ 
168 million and mortality of 1.1 million cattle (Mukhebi et al., 1992).  
T. parva has likely co-evolved in East Africa with its natural reservoir, the African buffalo 
(Syncerus caffer) (Norval et al., 1992). Transmission of buffalo-derived T. parva stocks to 
cattle results in severe forms of ECF (Corridor disease) associated with high mortality rates 
while circulation of T. parva within the cattle population results in milder forms of disease 
(Norval et al., 1991). Clinically, infection of cattle with T. parva is characterized by a persistent 
high fever, lymphadenopathy, infiltration of infected lymphocytes into lymphoid tissue, 
oedema and towards the end, leucopenia. Infection of exotic Bos taurus breeds, introduced to 
increase milk and meat production, results in high morbidity and mortality. Indigenous Bos 
indicus breeds show higher disease tolerance although morbidity and mortality may still be a 
major concern, particularly in calves (Norval et al., 1992; Kivaria et al., 2004). Younger 
animals are generally more tolerant to infection due to a combination of protective maternal 
antibodies and lower tick burdens (Norval et al., 1992; Marcotty et al., 2002). Endemic 
stability is observed in regions where repeated exposure of young animals through natural 
field tick challenge induces and boosts protective immunity.  Adult animal populations in these 
areas generally show no clinical signs of infection (Norval et al., 1992).   
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Rhipicephalus appendiculatus as vector of ECF 
The primary vector for T. parva transmission is the three-host tick Rhipicephalus 
appendiculatus (Lessard et al., 1990, Lawrence et al., 1994).  The distribution of R. 
appendiculatus over Africa is shown in figure 1. The preferred feeding hosts for all tick stages 
are cattle/African buffalo; additional hosts may include dogs and other small mammals, 
particularly for immature larval and nymphal stages (Norval et al., 1992; Walker et al., 2003). 
All three stages of the tick develop over a feeding period of four to seven days.  After feeding, 
the tick detaches from the host and undergoes molting or egg laying (in the case of engorged 
adult females).  Following this period of inactivity, ticks will find a suitable host and resume 
feeding or die in the case of spent adult females. The entire life cycle of R. appendiculatus 
can be completed within a minimum of three months but may take up to a year.  Each adult 
female can produce between 3000 and 5000 eggs (Norval et al., 1992; Walker et al., 2003). 
R. appendiculatus population growth is strongly dependent on climatic conditions. In southern 
Africa where R. appendiculatus completes one generation a year, ECF disease incidents are 
seasonal.  Adults occur from December to March coinciding with the onset of the rainy 
season and will only begin questing for a host after the onset of the rains.  Larvae hatch late 
in the summer towards the cooler winter period (April-August) and molt into nymphs in winter 
to early spring (July-October). In regions where rain is less seasonal, multiple tick generations 
can overlap each other and disease incidents may occur throughout the year (Norval et al., 
1991). In addition to T. parva, R. appendiculatus serves as vector for Theileria taurotragi 
(causing benign bovine theileriosis); Anaplasma bovis (causing bovine ehrlichiosis) and 
Rickettsia concori, (causing tick typhus in humans and Nairobi sheep disease virus) (Walker 
et al., 2003).   
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Figure 1: The distribution of R. appendiculatus over East and South-East Africa (Walker et al., 
2003). 
T. parva life cycle 
T. parva belongs to the sub-phylum Apicomplexa and genus Theileria.  The T. parva 
genome has been sequenced and it is distributed over four chromosomes with a total size of 
8.3 Mbp (Gardner et al., 2005). In contrast to Plasmodium, not all components of the apical 
complex are present in T. parva and entry into host cells is not orientation specific as with 
other apicomplexan parasites. Rhoptries and microspheres are not involved in the entry 
process but are involved in parasite establishment in the host cell after entry (Shaw et al., 
1991).  Maintenance of T. parva populations occurs through developmental stages alternating 
between the bovine host and tick vector (Figure 2).  During feeding, R. appendiculatus 
acquires T. parva piroplasms contained within erythrocytes from an infected animal. Most 
piroplasms are destroyed by acid phosphatases secreted by gut epithelial cells but remaining 
cells differentiate into male and female gametes. Fused gametes form a diploid zygote are 
able to penetrate the gut wall through an unknown mechanism.  Intracellular parasites remain 
free within the cytoplasm and are not contained within a parasitophorous vacuole (Shaw and 
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Young, 1994).  With tick molting, motile kinetes exit the gut wall into the hemolymph which 
provides a pathway to salivary glands. Within the salivary glands, sporozoite development 
occurs specifically within the ‘e’ cell of the type III acinus (Fawcett et al., 1982a, Fawcett et 
al., 1982b, Fawcett et al., 1985). Parasite multiplication through sporogony is induced at 
beginning of tick feeding although it can be artificially induced by elevated temperatures 
(Young an Leitch, 1981).   
Sporozoites are transmitted to the cattle host through saliva pumped into the feeding 
site during feeding. Components of tick saliva promote T. parva transmission, facilitating the 
entry of parasites into lymphocytes (Shaw et al., 1993). Multinucleated schizont parasites 
contained within the cytoplasm of host lymphocytes undergo proliferation resulting in 
synchronous division of parasite and host cell. The schizont appears to interact with host cell 
nuclear spindle ensuring that each daughter cell receives a T. parva parasite after division 
(Hulliger et al., 1964; Hulliger, 1965; Stagg et al., 1980; Dobbelaere and Heussler, 1999). 
Uncontrolled proliferation of T. parva transformed lymphocytes followed by infiltration of host 
tissue results in the major pathology of theileriosis (Norval et al., 1992). In vitro, T. parva 
sporozoites infect all lymphocytes apart from monocytes and neutrophils, although in vivo 
only infected T lymphocytes with α/β T cell receptors are observed (Baldwin et al., 1988; 
Morrison et al., 1996). A proportion of schizonts differentiate to merozoite stages resulting in 
the destruction of the host cell and liberation of parasites (Melhorn and Schein, 1985).  
Merozoite invasion of erythrocytes seems to occur in a similar manner to the invasion of 
lymphocytes (Shaw and Tilney, 1992).  Merozoites develop into piroplasm stage, infectious to 
the tick vector required for the completion of the life cycle. Intra-erythrocytic multiplication of 
piroplasms does not occur in Theileria species and transmission of T. parva within the tick is 
strictly trans-stadial. For the cycle to perpetuate, a tick must feed successively on a bovine 
host infected with T. parva and then on a second bovine host that is susceptible to infection. 
Feeding on an alternative host results in loss of infection by the tick (Norval et al., 1992; 
Bishop et al., 2004).  
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Figure 2.  Life cycle of T. parva alternating between the tick R. appendiculatus and the bovine 
host (Bishop et al., 2004). 
Control of R. appendiculatus and T. parva 
1. Disease tolerant breeds
Control of R. appendiculatus and T. parva occurs primarily through the use of disease 
tolerant breeds, chemotherapy and acaricide application (Norval et al., 1992). The continued 
use of acaricides for tick control has resulted in large-scale resistance development observed 
in a number of tick species such as Rhipicephalus microplus and Rhipicephalus decoloratus.  
Although resistance occurs more rapidly in one-host ticks, it is still a concern to three-host 
ticks such as R. appendiculatus (George et al., 2004). Additional concerns relating to 
acaricide use include environmental and product contamination as well as prohibitively high 
cost of infrastructure maintenance and acaricide purchase (Kocan, 1995; George et al., 
2004).  The use of tick-tolerant animals is the most viable method of risk reduction for small-
host signal transduction pathways thereby inducing
cancer-like syndromes in infected mammalian lym-
phocytes, monocytes and macrophages. The only
tick-expressed stage of Theileria for which any mol-
ecular information is currently available is the sporo-
zoite, which is secreted from the tick salivary glands
into the vertebrate host. This article will concentrate
on tick vector-associated aspects of Theileria biology
and will review the status of vaccine development
based on an antigen isolated from the tick-derived
sporozoite life cycle stage. The data presented pri-
marily relates toT. parva, the species for which most
information is currently available.
OVERVIEW OF THE THEILERIA PARVA
LIFE CYCLE
Theileria parva life-cycle stages in the tick vector
and bovine host have been comprehensively de-
scribed previously and are summarized in Fig. 1.
Fig. 1. Life cycle of Theileria parva in cattle and the ixodid tick vector Rhipicephalus appendiculatus.
Theileria in the ixodid tick vector S273
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scale farmers however the use of such animals is invariably associated with a reduction in 
animal productivity (Minjauw and McLeod, 2003). Certain cattle breeds such as Zebu and 
Sanga are known to be more resistant to tick infestations and better able to tolerate T. parva 
infections.  The use of either full or crossbred cattle allows survival of animals using minimal 
tick control strategies.  As severity of East Coast fever is dose dependent, animals able to 
deter tick infestations are less likely to be exposed to high levels of T. parva challenge 
(reviewed in Norval et al., 1992).   
2. Vaccination
The development of live vaccines has occurred for most livestock tick-borne diseases of 
significance with various levels of efficacy achieved (reviewed by Pipano, 1995). Attempts to 
produce live blood and in vitro culture sporozoite based vaccines for T. parva were generally 
unsuccessful (Pipano, 1995).  Development of the current Infection-and-Treatment Method 
(ITM) of immunization technique occurred in 1977 involving the inoculation of a lethal dose of 
isolated and cryopreserved T. parva sporozoites simultaneously with long acting 
oxytetracycline formulations (reviewed by di Giulio et al., 2009).  Such vaccination is possible 
due to the ability to harvest metabolically active T. parva sporozoites from infected tick 
salivary glands. Harvested sporozoites remain infective to susceptible cattle after 
cryopreservation and thawing, although, the quantitative effect on sporozoite viability is not 
known (di Giulio et al., 2009).  After inoculation, protective immunity is induced, based mainly 
on MHC class I restricted cytotoxic T cells (McKeever, 1990; Morrison and Goddeeris, 1990; 
McKeever and Morrison, 1994) and vaccinated animals are protected against lethal challenge 
with autologous parasites (Taracha et al., 1995,). Antigenic variation between T. parva strains 
exist and cross protection between strains is variable (Taracha et al., 1995).  Currently, three 
parasite strains are incorporated into the vaccine stabilate known as the Muguga Cocktail, 
namely Kiambu 5, Serengeti-transformed and Muguga (Radley, 1981; Dolan, 1987) and 
contributing genotypes within each stabilate determined (Patel et al., 2011).   
Although the vaccine has shown to be generally effective in terms protection, extensive 
adoption in the field has been low due to a number of reasons. Vaccination results in a carrier 
state in cattle and parasite transmission to non-vaccinated cattle may introduce new strains to 
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endemically stable regions (Oura et al., 2004; Oura et al., 2007). Due to antigenic diversity 
between parasite stocks, breakthrough infections can occur resulting in losses of animals 
despite vaccination. Cold chain delivery and storage is required to maintain parasite viability 
meaning that vaccination in remote areas is problematic.  Due to vaccine inoculation of live 
parasites, adverse reactions can occur despite treatment with oxytetracycline and animal 
monitoring after vaccination is recommended, which, depending on herd size, may be 
extensive (Minjauw and McLeod, 2003, di Giulio et al., 2009).  Production of the stabliate is 
complex and requires extensive in vivo testing for each batch to determine dose levels.  As a 
result, production of a million vaccination doses requires a staggering 130 head of cattle, 500 
rabbits and the application of at least 600 000 nymph R. appendiculatus ticks as well as 
skilled manpower for the dissection and harvesting of salivary glands (Radley et al., 1975; di 
Giulio et al., 2009). 
Intensive research into sub-unit vaccine development for T. parva has been carried out 
for the last 20 years.  A 67 kDa protein located on the surface of sporozoites (p67) is 
conserved among cattle-derived isolates (Musoke et al., 1992; Nene et al., 1996). Vaccination 
with p67 showed promise under laboratory needle challenge conditions although it was 
ultimately abandoned after repeated poor field performance (Musoke et al., 1992; Honda et 
al., 1998; Bishop et al. 2003; Kaba et al., 2005; Musoke et al., 2005).   
The major protective immune effector mechanism is thought to be mediated by a MHC 
Class I restricted CD8+ cytotoxic T cell response directed towards the schizont infected cell 
(Morrison and McKeever, 2006) and is discussed further in chapter 7. A schizont-stage 
specific subunit vaccine has been proposed to induce this protective response.  Five antigen 
candidates were identified based on recognition by MHC Class I restricted CD8+ cytotoxic T 
cell responses in cattle.  Development further than initial evaluation has not taken place 
mostly due to lack of appropriate antigen delivery systems for induction of cytotoxic T cells  
(Graham et al., 2006; Graham et al., 2007; Akloo et al., 2007). 
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Conclusion 
Currently, no method of ECF control which is both effective and meets the needs of 
diverse livestock production systems exists. Acaricide-based methods of ECF control are not 
sustainable and alternative control methods are desperately needed. With continuously 
increasing demands on milk and meat production, the use of low production T. parva resistant 
cattle breeds is no longer economically viable. Globally, acaricide use as the sole measure of 
tick control is problematic and integrated control strategies are generally seen as the way 
forward. The immunological control of ticks through anti-tick vaccination will likely represent a 
component of integrated control strategies for ticks and tick-borne diseases. Proven effective 
for the control of the cattle tick Rhipicepahlus microplus, immunization with anti-tick vaccines 
has resulted in effective tick and tick-borne disease control and reduced acaricide use (de la 
Fuente et al., 2007). Through the work reflected in this thesis, an extensive evaluation of anti-
tick vaccination for control of R. appendiculatus and T. parva was undertaken. A review on 
the history and current status of anti-tick vaccination in livestock is presented in chapter 2.  In 
chapter 3, the evaluation of the R. appendiculatus antigen Ra86 for its potential to control R. 
appendiculatus populations and the effect on T. parva transmission is discussed. Chapter 4 
focuses on the development and evaluation of a tick-based cattle infection model for T. parva. 
This tick-based model of T. parva infection was imperative for testing of a multivalent 
transmission blocking vaccine (chapter 5). Chapter 6 describes the adaptation of the R. 
appendiculatus Muguga tick stock to feeding in vitro using a silicone membrane system. 
Lastly, a preliminary investigation into the immune response of calves infected with tick-
transmitted T. parva is shown in chapter 7. 
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Abstract 
Ticks are obligate hematophagous arthropod parasites affecting most terrestrial 
vertebrate species.  Their importance as disease vectors is due to the abundance and 
diversity of organisms they transmit to their vertebrate host. In addition, secondary infections 
of the attachment site, direct toxicosis and paralysis can occur due to tick feeding.  The 
impact of tick-borne diseases is most heavily felt in the livestock sector, where production is 
limited in many areas due to high tick infestations and tick-borne disease prevalence. 
Currently, large-scale tick control is achieved through acaricide application but continued use 
has resulted in resistance to several active ingredients.  As an alternative, the immunological 
control of ticks through vaccination has been proposed.  Proof of concept has been shown 
culminating in commercial vaccines for the control of the cattle tick Rhipicephalus microplus.  
Despite this initial success the development of anti-tick vaccines faces a number of unique 
obstacles due to complex interactions between tick and vertebrate hosts.  This complexity 
does however allow novel areas of vaccine development to be followed that are unavailable 
to other vector-borne diseases.  Tick antigens localized in the tick gut are concealed from the 
host immune response during normal tick feeding.  With the uptake of the blood meal from a 
vaccinated host, damage to the gut wall occurs which may result in death or decreased 
reproductive capacity.  The use of ‘concealed antigen’ candidates has been successful in 
effectively reducing tick populations with successive generations.  Furthermore, a number of 
‘exposed antigen’ candidates, present in the saliva or cement cone, have also been 
investigated for their ability to interfere with tick feeding and block parasite transmission.  With 
the completion of tick genome sequencing projects the number of candidate antigens for 
evaluation as vaccine candidates increasing.  In this chapter the history and potential future of 
anti-tick vaccine development is outlined with particular reference to control of ticks and tick-
borne diseases affecting livestock.  Anti-tick vaccine advances for the major tick species 
affecting livestock, Rhipicephalus, Amblyomma and Hyalomma will be discussed.   
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Introduction 
Ticks are widely distributed throughout the world affecting 80% of the world’s cattle 
population1.  The economic importance of ticks and tick-borne diseases (TBD) has been 
estimated by a number of studies however they most likely represent an under estimation of 
the real impact of these arthropod vectors and their transmitted diseases.  This is partly due 
to studies having a single focus such as direct losses, cost of control etc. and partly because 
they often focus only on a single disease or tick species2,3,4.  To further complicate 
estimations, losses are measured differently for the livestock sector compared to 
human/companion animals. Tick feeding has devastating effects including disease 
transmission, paralysis, toxicosis and secondary infections of the tick-feeding site4,5.  The 
effect of ticks and tick-borne diseases is particularly pronounced in the livestock sector where 
it is repeatedly rated highly for its impact on the livelihood of farmers, particularly in countries 
of the South which are heavily dependent on agricultural production3,4. Heavy tick infestations 
in livestock can result in anemia, reduction of body weight, loss of body condition and hide 
damage, an important factor in leather production industries2,6. 
Although argasid ticks of veterinary importance exist, this review will focus solely on 
Ixodidae ticks.  There are six genera of ixodid ticks of importance, namely Amblyomma, 
Dermacentor, Haemaphysalis, Hyalomma, Rhipicephalus and Ixodes (summarized in table 
1).  Ixodes genus ticks are most well known for their transmission of Borrelia, the agents of 
Lyme disease common in Europe, Asia and North-America.  As this species is not of concern 
in the livestock sector, it will not be discussed further.   
Ticks can be tolerated on livestock if numbers remain low and the distribution does not 
overlap with its associated tick-borne disease.  In some instances, near complete eradication 
of ticks and tick-borne disease have been achieved, complete elimination of tick species from 
a geographic area is often not feasible7,8.  Historically, tick and tick-borne disease control has 
focused on the control of ticks at tolerable levels through acaricide use and treatment of 
disease with appropriate drugs.  In some cases acaricide-based tick control is often the only 
method of reducing tick populations without sacrificing productivity8,9..  Acaricides are 
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commercially available in a number of formulations that are applied either directly onto 
livestock or in dipping vats where multiple animals can be passed through at regular time 
intervals. Acaricide application relies heavily on correct formulation and administration to be 
effective9.  A large number of chemical compounds have been found to be effective against 
ticks including arsenic (introduced ≈1983), DDT (≈1946), cyclodienes and Toxaphene 
(≈1947), organophosphates-carbamate group (≈1955), formamides (≈1975) and macrocyclic 
lactones (≈1981).  The potency and usefulness of many of the above-mentioned compounds 
is gradually eroding with resistance developing in many tick species of Rhipicephalus, 
Amblyomma and Hyalomma.  Multiple acaricide resistant tick stocks have been identified, 
limiting or entirely excluded the use of many acaricides9-11.  In addition to resistance, 
chemical control through acaricide application results in environmental pollution and residue 
tainting of meat and milk products.   In economically weak countries, use of acaricides for tick 
control may be even less feasible due to the high cost involved in infrastructure maintenance 
and product purchase2.  For small-scale farmers, the formation of co-operatives may be an 
alternative to allow acaricide-based tick control12.  Where ticks have been removed by 
systematic acaricide application, collapse of protocols and infrastructure due to political 
unrest has resulted in the re-establishment of tick populations and high livestock mortality 
associated with disease outbreaks6.  
Vaccination against ticks 
The guiding principle for anti-tick vaccination stems from early studies conducted on 
acquired host resistance to tick infestations.  Repeated exposure of hosts to ticks or tick 
organ homogenates induced resistance to tick re-infestation.  While the degree of resistance 
may vary between different tick and host species, evidence strongly suggests that natural 
resistance against tick infestation develops based on adaptive immune response 
mechanisms13-15. Ticks feeding from hosts vaccinated with tick components take up effector 
molecules during feeding that mediate deleterious effects on the ticks.  This effect manifests 
as reduction of feeding time, tick mortality (during or after feeding), reduced engorgement 
weights and reduced reproductive capacity of adult females.  Eggs laid from ticks fed on 
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vaccinated hosts may also show reduced hatching rates.  The overall result culminates in 
reduction of tick populations and tick-borne diseases. 
There are several advantages of anti-tick vaccination over acaricide use for tick control.  
These include, reduced concerns regarding long-term contamination of animal products and 
environment with harmful residues and increased sustainability in terms of required 
infrastructure.  Additionally, the resistance development to anti-tick vaccines is likely to be 
slower than that against acaricides and the costs of anti-tick vaccine development, 
production and registration is thought to lower than for a new acaricidal compound (estimated 
at US $ 100 million)5,16,17.  Although anti-tick vaccination is often viewed as an alternative to 
acaricide usage, it can also be seen as a complementary approach within the framework of 
integrated pest management approaches (IPM).  Where used appropriately, anti-tick 
vaccination results in reduction of acaricide use and potentially decreases acaricide 
resistance development5,17-20.  
Anti-tick vaccine candidates 
Many of the anti-tick vaccine targets have been identified using conventional immune-
screening techniques.  Immunization of vertebrate hosts with tick homogenates or purified 
tick extracts generates immune sera.  These sera are used to screen for tick antigens 
detected by the host.  The identification of tick proteins essential for tick survival is a useful 
method for more targeted antigen discovery, which is made increasingly possible as 
information is gathered on tick biology. With the availability of genome sequences for a 
number of tick species, the number of candidates for discovery is expanding through reverse 
vaccinology.  A repository of the R. microplus genome data is a valuable resource for 
candidate mining21 and hopefully, such repositories for other important tick species will 
follow. The use of other techniques such as RNA interference (RNAi) has been useful in 
confirming the importance of anti-tick vaccine candidates and is likely to play a role in future 
anti-tick vaccine antigen discovery22. 
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Anti-tick vaccine candidates have been classified into two categories: exposed or 
concealed antigens.  Exposed antigens are secreted in tick saliva during attachment and 
feeding on a host while concealed antigens are normally hidden from the host immune 
response. While Willadsen proposed that antigens should rather be classified according to 
structure or function5, the main advantage of using the exposed vs. concealed distinction is 
that it has obvious important implications for potential immune evasion mechanisms by the 
tick. Molecular mimicry by ticks of host components has been observed and vaccination may 
induce host sensitivity and auto-immune reactions when exposed antigens are used23.  One 
advantage of using exposed antigens is that natural boosting occurs through tick feeding. 
Mechanistically, vaccination with exposed antigens is thought to induce a focal hostile 
environment unsupportive for tick attachment and feeding.  Concealed antigens do not come 
into contact with the host immune response during natural tick feeding.  Although often 
contained within the thoracic cavity of the tick, some salivary gland proteins can be 
characterized as concealed if they are not secreted into the tick-feeding site.  One difficulty in 
the development of concealed anti-tick vaccines is that the antigen must be accessible to the 
induced humoral vaccine response.  This often limits the number of candidates to those 
coming into prolonged and direct contact with the blood meal or where the humoral response 
can be transported over the gut barrier into the haemolymph24-26.  The second limitation of 
concealed antigens relates to natural boosting of the immune response.  As the antigens do 
not come into contact with the immune response within the host, sufficiently high antibody 
levels must be induced through repeated vaccination.  On the positive side, there is low 
natural selection pressure on these antigens and emergence of resistance is not of major 
concern.  As the blood meal acts as the carrier for the effector immune responses, the anti-
tick effect can take place over a longer period of time compared to exposed antigens.  This 
effect may even extend beyond the mere feeding period into the inactive stages where 
digestion and molting/egg laying takes place. 
Review of successful anti-tick vaccine candidates 
The Bm86 based anti-tick vaccine remains the only anti-tick vaccine commercially 
produced and has become the benchmark for future anti-tick vaccine development and 
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evaluation. The gut-associated Bm86 glycoprotein was first identified in R. microplus although 
homologues in other tick species have since been identified27,28,29,30,31,32,33.  The biological 
function of Bm86 remains unknown although it is thought to play a role in the digestion of the 
blood meal34.  In R. microplus, expression of Bm86 is increased during embryogenesis 
reaching the highest level in unfed larvae.  Expression decreases during feeding and molting 
with lowest levels of expression detected during the resting stages of the tick35.  Bm86 has a 
translated coding sequence of 650 amino acids and a size of 71.7 kDa.  The protein contains 
four potential N-linked glycosolation sites and a leader peptide suggesting transport to the cell 
surface28.  Localization studies have shown the molecule is located predominantly on the 
microvilli of gut epithelial cells29,36.  A single C terminal transmembrane sequence is present 
in the unprocessed protein which is replaced by a glycosyl-phosphatidyl inositol anchor in the 
mature protein.  The protein also contains multiple predicted EGF repeats rich in cysteine 
residues28,34.   
Vaccination has been performed mostly with the whole molecule and protective epitopes 
for Bm86 have not been well determined.  The site of a protective B-cell epitope was defined 
and additional epitopes are likely to exist37.  Overlapping cross-reactive immune-reactive 
epitopes have been found between Bm86 and the R. decoloratus homologue, Bd8636,38.  
Vaccine efficacy is directly related to anti-Bm86 antibody titre and ability to control tick 
populations is directly related to achieving a strong antibody response39-42.  Substantial 
animal-to-animal variation has been observed in the ability to generate anti-Bm86 antibody 
titres which is likely related to the MHC Class II haplotypes expressed42.  Antibodies to Bm86 
and cattle complement system are taken up during the blood meal.  Antibody binding results 
in lysis of the gut epithelial cells culminating in impaired blood meal digestion. Strong antibody 
responses may induce tick mortality due to blood leakage from the gut into the hemolymph 
and ticks may turn reddish instead of grey34.  
Recombinant expression of Bm86 has been attempted in several expression systems 
including Escherichia coli34, Aspergillus nidulans43, Aspergillus niger and Pichia pastoris45-48.  
Vaccine trials showed that Bm86 vaccination targeted mainly the adult stage of R. microplus, 
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particularly, the number of adult females fully engorging and post-engorgement mortality.  
Reproductive capacity of adult R. microplus females was affected in terms of egg laying 
capacity and hatching of eggs5,49.  
 
Under field situations, vaccination of cattle reduced tick numbers by 56 % within a single 
generation and reduced the reproductive capacity by 72%50.  Reversal of negative effects of 
tick feeding on live weight of vaccinated animals by an average increase in live weight of 18.6 
kg over a six-month period was observed40,41.  Extensive field trials in Cuba, Brazil, Argentina 
and Mexico showed between 55 and 100% control of R. microplus ticks within a 36-week 
period42,51.  Importantly, complete control of acaricide resistant ticks could be accomplished 
by integrating Bm86 vaccination with acaricide use52 showing that integrated control systems 
are effective in controlling tick populations.  Vaccination also decreased the amount of 
acaricides required to control tick populations and prolonged the time interval between cattle 
dipping5.  Bm86 vaccination has been extensively evaluated for its ability to control other tick 
species.  Almost complete cross-protection against Rhipicephalus annulatus has been 
reported53,54. Significant protection against Hyalomma anatolicum, H. dromedarii and R. 
decoloratus has been observed however no cross-protection however was seen against R. 
appendiculatus or Amblyomma variegatum38,55.   
 
Amino acid sequence variations in Bm86 exist between different stocks of R. microplus 
and this was thought to contribute to differences in vaccine effectiveness over different 
geographic locations. Thus far, no definite correlation between vaccine effectiveness and 
Bm86 sequence homology has been shown5.  A laboratory R. microplus tick strain from 
Argentina was shown to be resistant to Bm86 vaccination47,51 and the nucleotide sequence of 
the Bm86 gene showed substantial differences including 21 amino acid substitutions (out of 
610 amino acids in the mature protein)56.  The protein was subsequently renamed to Bm95 
although whether it should be separately classed remains debatable.  Bm95 has been 
successfully produced in P. pastoris48 and incorporated in a number of vaccine trials.  Effects 
of Bm95 vaccination are similar to Bm86 vaccination with tick rejection, damage and death.  
Decreases in engorgement weights, oviposition and egg hatching are also demonstrated57.  A 
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high level of cross-protective vaccine efficacy against Indian Rhipicephalus 
haemaphysaloides with Bm95 vaccination has been illustrated in cattle58. Using a novel 
production technique, fusion of immunogenic Bm95 peptides and the A. marginale MSP1 N-
terminal region was protective against R. microplus infestations in rabbits.  The reduction of 
tick oviposition and fertility was comparable to the commercial Bm86 vaccine59,60. 
Commercialization of Bm86 derived vaccines 
Commercialization of the Bm86 anti-tick vaccine in Australia under the name TickGard™ 
was undertaken by Commonwealth Scientific and Industrial Research Organization (CSIRO) 
in collaboration with Biotech Australia Pty. Ltd., and released by Hoechst Animal Health in 
1994.   Within four years, the commercial success of TickGard™ grew till it became the 
highest value tick treatment product in Australia.  Unfortunately, a series of changes within 
the commercial partners involved in TickGard™ production and distribution resulted in 
discontinuation of production. The vaccine was briefly re-introduced by Intervet Australia Pty., 
Ltd. (Bendigo, Australia) but it currently not available for sale20.  The Gavac Bm86 based 
vaccine has been far more successful in areas of Latin America.  It was developed by the 
Center for Genetic Engineering and Biotechnology (Havana, Cuba) and released by Herber 
Biotec S.A. (Havana, Cuba) in 1993. The vaccine has been extensively used in Cuba where it 
has resulted in reduction of babesiosis and anaplasmosis as well as a dramatic reduction in 
required acaricide use20,42,61.  Due to state mandated control programs, Cuba illustrates a 
best-case scenario outcome for anti-tick vaccine deployment20.  The vaccine was registered 
in 1994, 1995 and 1997 for Colombia, Brazil and Mexico, respectively, with these countries 
reporting on similar control levels achieved20. 
Bm86 homologues of other tick species and their vaccine potential 
Homologues of Bm86 from a range of other tick species have shown promise as tools for 
tick control.  Bm86 vaccination of cattle induces cross-reacting antibodies binding to gut 
sections of R. decoloratus although its anti-tick effect has not been determined.  Mouse 
monoclonal antibodies induced against a synthetic Bd86 derived peptide recognized Bm86 
homologues in R. microplus, R. decoloratus, H. anatolicum anatolicum and R. 
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appendiculatus35.  Identification and RNAi silencing of the Haemaphysalis longicornis Bm86 
homologue showed a significant reduction in tick engorgement weight62. The R. annulatus 
homologue of Bm86, Ba86 has been successfully expressed in P. pastoris and evaluated in 
cattle.  Vaccination significantly affected tick infestations, oviposition and egg fertility. 
Additionally, cross protection occurred between Ba86 and R. appendiculatus ticks. 
Interestingly, the efficacy of both Ba86 and Bm86 was higher for R. annulatus than for R. 
microplus indicating that Bm86-like effects may be tick species dependent rather than 
sequence homology dependent60. Vaccination of cattle with H. anatolicum anatolicum 
homologue, Haa86, resulted in significant increase in tick rejection, reduction of tick 
engorgement weights and egg mass32.  The effect of Bm86 homologue vaccination on the 
transmission of tick-borne diseases has been rarely studied. In one study, Haa86 vaccination 
reduced transmission of Theileria annulata parasites to susceptible calves63. The expression 
pattern of the R. appendiculatus Bm86 homologue, Ra86, is notably different to the Bm86 
expression35.  In a laboratory tick stock of R. appendiculatus, Ra86 homologs exist as two 
highly divergent allelic variants.  Nucleotide sequence similarity between Ra86 and Bm86 is 
73% and 74% for the two variants Ra85A and Ra92A, respectively33.  Vaccination of rabbits 
with baculovirus expressed Ra86 variants significantly affected engorgement weight and egg 
weight64.  None of these effects could be replicated in the bovine host using the same 
baculovirus construct for expression of Ra86 homologues.  However, a previously unreported 
significant effect on the molting of nymph ticks to the adult stage occurred after Ra86 
vaccination of cattle65. 
Other anti-tick vaccine candidates 
A number of other anti-tick vaccine candidates have shown promise for control of both 
homologous and heterologous tick species, although none have been taken beyond initial 
proof-of-concept studies.  These antigens are summarized in table 2. 
Dual action anti tick vaccines 
A dual action anti-tick vaccine candidate represents a novel concept in that exposed 
antigen share antibody binding epitopes with a concealed antigen. The advantage of this 
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group of antigens lies in the fact that natural boosting occurs through exposed epitopes while 
targeting concealed antigens. The best studied of these dual action candidates is the 64P 
protein also known as TRP64 and 64TRP. The protein identified in R. appendiculatus is 15k 
Da and appears to form part of the cement cone66.  Cross-reactive epitopes were found within 
the salivary glands, hemolymph, midgut of adult females and whole body extracts for larvae 
and nymph R. appendiculatus66.  One of the striking features of this antigen is that 
vaccination of truncated versions affected different stages of ticks66. Vaccination mediated 
effects manifested as engorgement weight and egg mass reduction and direct tick mortality66. 
Inflammatory and adaptive immune responses induced by vaccination with TRP64 disrupt tick 
feeding. Where feeding does occur antibodies taken up bind to cross-reactive midgut 
epitopes, rupture of the tick midgut and death of engorged ticks occurs66.  A broad, cross-
protective effect was seen against I. ricinis, R. sanguineus, A. variegatum and R. microplus. 
This cross-reaction may be based on strong epitope conservation in the different tick species 
to maintain molecular mimicry of host collagen and keratin66-68 and natural boosting of 
antibody titres clearly occurs after tick infestation67.   
While anti-tick effects have been demonstrated in mice and guinea pigs66,67 it failed to 
show an effect in rabbits using a baculovirus prepared antigen64.  Furthermore, no tick effect 
could be established using a bacterial expressed TRP64 as part of a multivalent vaccine in 
cattle (Olds et al., manuscript in preparation). The potential of TRP 64 as anti-tick vaccine 
candidate was substantiated after transmission blocking of tick-borne encephalitis virus to 
susceptible mice by I. ricinus ticks.  The protective effect of the 64TRP vaccine was 
comparable to that of a single dose of a commercial tick borne encephalitis vaccine69. 
During the uptake of the blood meal, the amount of iron increases dramatically in the tick 
gut where tick ferritins act as iron-storage proteins.  Ferritin 2 (Fer2) is a gut-specific protein 
secreted into the tick hemolymph where it acts as an iron transporter. It is expressed in all tick 
developmental stages and silencing by RNAi of Fer2 has an adverse impact on tick feeding, 
oviposition and larvae hatching70.  Vaccination of cattle with recombinant homologues of Fer2 
in Ixoded ricinus and R. microplus showed excellent control of R. ricinus and R. microplus 
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and R. annulatus for the R. microplus homologues71.  Notably, the vaccine efficacy of 
recombinant Fer2 was comparable to the benchmark obtained with Bm86 vaccination against 
R. microplus71. 
An antigen that received much attention is subolesin. Initially termed 4D8, the antigen 
was first discovered in Ixodes scapularis72 but it has been characterized in several other tick 
species73-75.  Targeted reduction of subolesin mRNA using RNAi resulted in degeneration of 
tick gut, salivary glands, reproductive tissues and embryos74-78. Immunization of cattle with 
recombinant subolesin resulted in reduced R. microplus survival and reproductive 
capacity79,81.  Additionally, subolesin was found to control tick gene expression and impact the 
tick innate immune response to pathogens reducing tick infection by tick-borne diseases 
Anaplasma marginale, Anaplasma phagocytophilum and Babesia bigemina77,80-86. Most 
recently, immunogenic peptides of subolesin were fused to the A. marginale MSP1a N-
terminal region, named SUB-MSP1a30,59,77,87.  Vaccination of cattle showed high efficacy for 
control of R. microplus and R. annulatus through negative impact on tick reproduction and 
egg fertility87. 
Transmission blocking anti-tick vaccines 
An anti-tick vaccine able to reduce or block transmission of pathogens from the tick 
vector to the vertebrate host would aid in TBD control. Transmission blocking vaccines would 
be ideal in allowing endemic stability development by reducing clinical disease incidence in 
vaccinated herds. It is well known that saliva aids the transmission of many tick-borne 
diseases. Saliva-activated-transmission (SAT) is termed as ‘the indirect promotion of tick-
borne pathogen transmission via the actions of bioactive tick saliva molecules on the 
vertebrate host’88.  Ixodes scapularis salivary gland protein P11 facilitates migration of 
Anaplasma phagocytophilum from the tick gut to salivary glands89.  The rate of in vitro 
infection of lymphocytes by Theileria parva is increased in the presence of R. appendiculatus 
salivary gland extracts90.  Targeting these SAT components seems to be ideal for 
transmission blocking however, more research is required to identify suitable non-redundant 
candidates.  
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The future of anti-tick vaccine development 
The ongoing genome projects of several tick species will provide the community with a 
wealth of potential novel candidates to be tested as anti-tick vaccines17,21. The use of RNAi 
experiments can help to functionally prioritize candidates that will be taken further for the 
study through genetic manipulation of ticks22.  Ideally, future anti-tick vaccines should 
simultaneously target a range of tick species since several tick species may co-feed on 
livestock.  A broad action anti-tick vaccine may be developed by identification of antigens with 
common, conserved and essential functions across several tick species or by incorporation of 
multiple antigens into a cocktail.   
After the identification of novel candidates, evaluation in the suitable animal model is of 
paramount importance. Testing of candidates in small animal models is accessible to many 
research laboratories around the world.  Large animal facilities handling livestock 
experiments however are expensive and rare. Additionally, for many ticks and TBD, 
appropriate in vivo challenge models have not been developed yet. However, it has been 
shown several times that sera generated from tick immune animals through repeated tick 
infestation detect different spectra of tick antigens depending on the animal species used. 
This difference in immune-dominance of tick components is most likely a consequence of 
long-term host pathogen co-evolution23. One clear example is seen when Rhipicephalus 
sanguineus ticks are fed on non-natural hosts like guinea-pigs.  Resistance to tick infestation 
is developed even after a low number of tick-bites manifested as high tick mortality, reduced 
female tick weight and reproductive capacity91.  In contrast, when R. sanguineus ticks are fed 
on dogs (their natural host), the reaction is significantly reduced, and mainly restricted to 
immediate inflammatory responses in the skin with a reduced delayed hypersensitivity 
response91.  Molecules present in tick saliva are thought to inhibit the host immune response 
and in non-host species, repeated tick exposure results in immune responses not present in 
the natural host systems23.  When testing the identical vaccine candidates for efficacy in 
different host-pathogen interaction systems conflicting results are often observed. Therefore, 
evaluation of novel candidates should be carried out at an early developmental step in the 
relevant natural host.  
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The commercialization of novel anti-tick vaccines should also take into account the 
lessons learned from Bm86 development20.  Despite being commercially available, the 
vaccine would not be deemed a commercial success.  The only two commercial products 
based on Bm86, Gavac and TickGard are either limited to used in Latin America or removed 
from the market, respectively. This is striking for a product that targets a highly economically 
important tick species with a global distribution. Expectations regarding the performance of 
an anti-tick vaccine should be explained thoroughly to consumers. Since the eradication of 
distinct tick species from the globe is unrealistic, anti-tick vaccines will be most likely play a 
part in integrated pest control strategies. These strategies have shown to reduce both tick 
load and TBD transmission and have the potential to fulfill farmer and government 
requirement for disease control20,92,93.  Early integration of testing anti-tick vaccines together 
with acaricide treatment schedules will probably pave the way for efficient commercialization 
of novel products in conjunction with better farmer product information.  
In conclusion, the need for novel methods of tick and TBD control is growing and there 
seems to be acceptance of farmers willing to use anti-tick vaccination94.  Development of 
novel commercial anti-tick vaccine products is beyond the possibilities of most academic 
institutions and novel public-private partnerships could speed up substantially the 
establishment of sustainable, cheap and environmentally friendly tick and TBD control 
strategies globally17. 
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Tables and figures 
Figure 1:  Due to their large mouthparts, feeding by Amblyomma ticks may result in severe 
secondary infections of the tick feeding site A: Amblyomma variegatum adult male tick, B: 
Amblyomma variegatum adult female tick 
A 
B 
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Figure 2: Adult Rhipicephalus appendiculatus tick.  Most known for the transmission of 
Theileria parva to cattle (East Coast fever), the tick species also transmits Theileria taurotragi 
(beningn bovine theileriosis), Anaplasma bovis (bovine ehrlichiosis), Rickettsia concori (tick 
thyphus) and Nairobi sheep disease virus. 
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Figure 3:  Immature Rhipicephalus ticks feeding on the ear of cattle (courtesy of S. Mwaura) 
Figure 4: Immature Rhipicephalus ticks feeding around the eye of cattle (courtesy of S. 
Mwaura) 
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Figure 5: Collection of acaricide resistant adult Rhipicephalus ticks in Kenya (courtesy of S. 
Mwaura) 
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Table 1: A summary of important tick and tick-borne diseases of livestock4. 
Genus Distribution Tick borne diseases 
   Amblyomma Widely distrubuted 
through Africa (A. 
variegatum), South 
East Africa (A. 
hebraeum)  
Cowdriosis of ruminants [Ehrlichia (Cowdria) ruminantium 
(Rickettsia)] 
Benign theileriosis of cattle [Theileria mutans (Protozoa)] 
Severe secondary infections of tick feeding site in cattle 
Dermacentor Europe, Asia, North 
America, Africaa 
Bovine anaplasmosis [Anaplasma marginale (Rickettsia)] 
Equine babesiosis [Babesia caballi (Protozoa)] 
! ! !
Haemaphysalis Asia, Europe and 
lesser extent in 
Australia 
Bovine babesiosis [Babesia ovata (Protozoa)] 
East Asian bovine theileriosis [Theileria buffeli (Protozoa)] 
Babesiosis of small ruminants [Babesia motasi (Protozoa)] 
Bovine babesiosis [Babesia major (Protozoa)] 
! ! !
Hyalomma Asia, Europe, Africa Bovine tropical theileriosis [Theileria annulata (Protozoa)] 
Theileriosis of small ruminants [Theileria lestoquardi (Protozoa)] 
! ! !
Rhipicephalusb America (North and 
South), Africa, Asia, 
Australia, Europe 
Bovine babesiosis [Babesia bovis and Babesia bigemina 
(Protozoa)], 
Theileriosis of cattle [Theileria parva (Protozoa)]
Benign bovine theileriosis [Theileria taurotragi (Protozoa)]
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Equine piroplasmosis [Theileria equi and Babesia caballi 
(Protozoa)] 
Bovine anaplasmosis [Anaplasma marginale, Anaplasma 
centrale (Protozoa)] 
Babesiosis of small ruminants [Babesia ovis (Protozoa)] 
Anaplasmosis of small ruminants [Anaplasma ovis (Protozoa)] 
!! !! !!
a Although present in Africa, not considered important 
b The Rhipicephalus genus now includes tick species formerly known as Boophilus.  Most important tick genus and includes cattle tick Rhipicephalus 
microplus, the main vector for bovine babesiosis and Rhipicephalus appendiculatus the vector for East Coast fever (bovine theileriosis) in cattle. 
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Table 2: List of anti-tick vaccine candidates evaluated for the control of ticks on livestock 
Antigen'' Location'and'function' Effect'of'vaccination' References'
' ' ' 'BMA7! 63 kDa membrane bound glycoprotein
widely distributed in tick tissues.   
Vaccination with R. microplus BMA7 
showed significant protection against tick 
infestation. 
95!
Biological function unknown  Effect was less than the Bm86 mediated 
vaccination 
!  !SBm7462 The synthetic peptide SBm7462 derived 
from Bm86 
Cattle!vaccination!resulted!in!a!efficacy!above!
80%!!
37 
!
Bm91 Membrane-bound carboxydipeptidase Increases the effect of Bm86 vaccination 96,97 
Identified in R. microplus 
Located in the tick salivary gland 
! ! ! !Serine proteinase 
inhibitors 
The serine proteinase inhibitors (serpins) 
have been the focus of a number of 
promising anti-tick vaccine studies. 
Vaccination!of!rabbits!with!recombinant!HLS1!
resulted!in!44!%!and!11!%!mortality!in!nymph!
and!adult!ticks,!respectively!
98H101!
Vaccination!of!rabbits!with!H.!longicornis!
serpinH2!resulted!in!a!mortality!rate!of!45%!and!
43%!in!nymph!and!adult!ticks,!respectively.!
!
Four!serpins!have!been!identified!in!R.!
appendiculatus,!named!RAS1H4.!Vaccination!of!
cattle!with!recombinant!RAS1!and!RASH2!
conferred!protective!immunity!with!61%!
reduction!in!nymphal!engorgement!weight,!28!
%!and!43!%!adult!female!and!male!mortality!
rate,!respectively.!
!
! ! ! !
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Troponin I-like 
protein 
Isolated from H. longicornis and induced 
specific antibody responses in both rabbits 
and mice. Located in muscle, cuticle, gut, 
and salivary glands.  
Vaccination of mice and rabbits resulted in 
significant extension of feeding times for 
larvae and adult ticks, low larval 
engorgement rates and reduction in egg 
weights. 
102H104!
!
Vitellin Most abundant yolk protein of R. microplus 
eggs.  Antibodies raised to vitellin also 
recognized a 200 kDa polypeptide in the 
hemolymph of adult tick. 
In its native form induced an immune 
response protecting sheep against 
infestation with B. microplus. 
105!
!
Voraxin Engorgement!factor! Rabbits immunized against the A. 
hebraeum voraxin, engorgement was seen 
to be reduced by 74% while all ticks fed on 
control rabbits fully engorged.  
106!
! !
Glutathione S-
transferases 
Glutathione S-transferases (GST) are a 
family of enzymes involved in detoxification 
of xenobiotics and endogenous 
compounds and they have been identified 
in a number of tick species. 
Recombinant H. longicornis GST-Hl as an 
anti-tick vaccine candidate has been 
evaluated in cattle for cross protection 
against R. microplus where an overall 
vaccine efficacy of 57% was shown against 
R. microplus. 
107H111!
!
RIM36 Isolated from R. appendiculatus and it is 
present in salivary glands (type III salivary 
gland acini) and the cement cone 
Immunodominant, under natural infestation 
vaccination of cattle did not induce a clear 
protective effect although strong antibody 
responses were induced.  
112H114!
!
HL34 Saliva protein identified in H. longicornis 
through tick saliva immune rabbit serum 
immuno-screening of an adult tick cDNA 
library. 
Vaccination of rabbits resulted in increased 
morbidity and mortality in nymphal and adult 
stages of H. longicornis although the effect 
did not reach statistical significance. 
115!
!
p29 29-kDa extracellular matrix-like protein 
from H. longicornis is thought to be a 
component of the cement cone. 
Recombinant p29 immunization of rabbits 
resulted in mortality rates of 40% and 50% 
of H. longicornis larve and nymphs, 
116!
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respectively.  Reduction in engorgement 
weight of adult female ticks of 17% was 
noted. 
!
Histamine binding 
protein 
Identified in R. appendiculatus and has a 
role in itch response 
No anti-tick effect in multivalent vaccination.  
Mild transmission blocking effect 
117 
! ! ! !Male
Immunoglobulin-
binding protein 
Identified in R. appendiculatus Vaccination of guinea pigs resulted in slight 
female feeding impairment 
24 
! ! ! !β-N-
acetylhexosamini
dase 
Identified in R. microplus Direct injection of rabbit polyclonal 
antibodies into replete females resulted in a 
26% reduction in oviposition.  No evaluation 
as a recombinant vaccine 
118,122 
! ! ! !5’-nucleotidase Identified in R. microplus Inactive, truncated form of the protein 
produced a significant effect in sheep only 
where high antibody titres were induced.  
No effect in cattle 
119,120 
! ! ! !
Calreticulin Identified in A. americanum, R. microplus  Poorly Immunogenic in cattle, no effect 121 
! ! ! !
Yolk pro-
Cathepsin 
Identified in R. microplus Antigenic in cattle, vaccination resulted in a 
protection rate of 25 % 
123-126 
!! !! !! !!!
AIMS AND OBJECTIVES 
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Aims and Objectives 
General Aim 
Novel approaches to integrated control of ECF and its tick vector, R. appendiculatus, are of 
paramount importance for sustainable meat and milk production in East and southern Africa. 
This thesis aimed to develop novel approaches for the development and evaluation of anti-
tick and ECF transmission blacking vaccines in the natural host – pathogen – vector system. 
Specific Objectives 
I. Evaluate the concealed tick gut antigen Ra86 as vaccine candidate for control of R. 
appendiculatus and T. parva 
II. Develop a controlled tick infection model for T. parva
III. Asses a multivalent transmission blocking vaccine for ECF
IV. Establish an in vitro feeding system for R. appendiculatus!
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Abstract 
The study of tick-borne diseases in livestock typically employs needle administration of 
pathogens as an experimental challenge approach, although this does not accurately reflect 
the parasite challenge encountered under field conditions. We demonstrate that Theileria 
parva can be transmitted to cattle by a distinct Rhipicephalus appendiculatus tick line 
selected to deliver a T. parva challenge reproducing that encountered in the field. 
Interestingly, these animals were protected against a subsequent lethal sporozoite needle 
challenge indicating induction of protective immune responses. This model for East Coast 
fever can serve as a defined autologous challenge model for vaccine trials and infection 
studies in cattle. 
Keywords 
Theileria parva, Rhipicephalus appendiculatus, tick-cattle challenge model, tick-borne disease 
Main text 
The tick-borne apicomplexan parasite Theileria parva causes East Coast fever (ECF) in 
cattle, which is one of the most devastating diseases of livestock in sub-Saharan Africa. ECF 
results in high mortality and morbidity affecting all sectors of livestock production, particularly 
exotic Bos taurus dairy cattle and Zebu (Bos indicus) calves where T. parva infection may 
result in up to 50% of calf mortality in affected areas (Kivaria et al., 2004; Norval et al., 1992). 
The three-host brown ear tick, Rhipicephalus appendiculatus is the primary vector of T. parva 
with all tick life stages adapted to feeding on cattle. East Coast fever transmission is strictly 
trans-stadial with larval or nymphal tick stage infection occurring during feeding, and 
transmission to susceptible cattle occurring during feeding of nymphal and adult stages, 
respectively (Norval et al., 1992). Transmission efficiency of T. parva differs between tick life 
stages and adult male and female ticks.  Development of infective sporozoites occurs in the 
‘e’ cells of type III acini of tick salivary glands. Adult females contain the highest levels of ‘e’ 
cells followed by adult males with nymphal ticks having the lowest levels. Despite their 
abundance of ‘e’ cells, adult male ticks are not considered efficient vectors due to irregular 
rates of sporogony and intermittent feeding (Ochanda et al., 1996). In addition to transmission 
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differences between sexes and life stages, it has been shown that tick stocks vary in their 
competence as vectors of T. parva (Ochanda et al., 1998; Odongo et al., 2009). Young et al. 
demonstrated that susceptibility of ticks to T. parva infection represents a heritable trait that 
can be manipulated to produce high- or low-level transmitting stocks by selective breeding of 
siblings families that exhibit high or low levels of vector competence  (Young et al., 1995).  
The severity of ECF is directly related to the dose of T. parva sporozoites delivered 
(Norval et al., 1992). Experimental infection of cattle with T. parva is currently performed 
using needle-based administration of cryo-preserved sporozoites harvested from 
homogenized R. appendiculatus salivary glands. Simultaneous inoculation of cattle with an 
estimated 5.9 x 104 live sporozoites and a long acting formulation of tetracycline form the 
basis of the ‘infection and treatment’ method of vaccination against ECF (reviewed by Di 
Giulio et al., 2009). Bovine Lymphocyte Antigen (BoLA) class I restricted, CD8+ cytotoxic T 
cells are currently the only well characterized effector mechanism for host control of T. parva 
elicited by the ‘infection and treatment’ live immunization method (Di Giulio et al., 2009). 
During tick feeding, sporozoites trickle into the cattle host over a period of several days and 
the simultaneous inoculation of high parasite numbers is unlikely to occur naturally as with 
needle challenge (Konnai et al., 2007). In addition, ticks inject a cocktail of molecules that 
modulate host immune and inflammatory responses and may also directly influence the ability 
of pathogens to infect host cells (reviewed by Wikel, 1999; Schoeler and Wikel, 2001). 
Despite these essential differences, needle-based experimental infection of cattle with T. 
parva has, to date, been the only mechanism used to assess T. parva vaccine candidates for 
induction of protective immune responses  (reviewed by Morrison and McKeever, 2006). We 
report here a novel, defined experimental tick-challenge model for T. parva. A selected R. 
appendiculatus tick stock named RAM-L, experimentally infected with T. parva, reliably 
transmitted T. parva sporozoites to naïve cattle. Following single exposure to tick delivered T. 
parva, all cattle were solidly protected against homologous lethal needle challenge.  
The R. appendiculatus Muguga ‘low-line’, RAM-L, used for this study was developed and 
maintained at the International Livestock Research Institute (ILRI) Tick Unit. The 
differentiation of the original Muguga tick strain into distinct high- and low-transmitting tick 
lines involved the cross-breeding of siblings with greater or lesser susceptibility to T. parva 
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infection (Young et al., 1995). Uninfected ticks were maintained in Biological Oxygen Demand 
(BOD) incubators at 28 ± 1 °C and T. parva infected ticks at 24 ± 1 °C, 80% relative humidity. 
The T. parva Muguga strain was originally isolated from the Kiambu District of Kenya and has 
been maintained as laboratory stock through a series of tick passages (S. Mwaura, 
unpublished data). 
To infect approximately 2000 RAM-L ticks with T. parva, a Friesian calf (Bos taurus), four 
months of age and free of detectable tick-borne pathogens was infected with a lethal dose of 
T. parva Muguga (ILRI stabilate 3087, 1 mL dose of 1:20 dilution) by subcutaneous injection 
under the right parotid lymph gland. Treatment with a short acting oxytetracycline formulation 
was administered on days 11, 12, 13 and 15 post-infection to control ECF symptoms and 
allow tick feeding over the period of patent piroplasm parasitemia. Rectal temperature was 
recorded daily and from day 5 post-infection, ear vein smears and lymph node biopsies were 
taken daily. Two thousand RAM-L nymphs were applied in a bag secured to the back of the 
animal on day 12 post infection, two days prior to the onset of piroplasm parasitemia. Ticks 
fed over a maximum period of seven days, and detached over a period of four days.  Ticks 
from each day of detachment were pooled and designated as batch 1 – 4. Detached nymphs 
were placed into BOD incubators for six weeks to allow molting to adults and sorted into male 
and female ticks.  Thirty adult male and thirty adult female ticks from each batch were pre-fed 
for four days on the ears of rabbits to induce sporozoite maturation within tick salivary glands. 
The infection rate was determined as the percentage of ticks with infected acini and 
abundance as the average number of infected acini per tick. Infection levels were determined 
by microscopic examination of Feulgen’s stained salivary glands. 
T. parva infection parameters for the four RAM-L tick batches collected are shown in 
Figure 1. Overall infection rates were similar to natural field occurring tick infection rates in 
areas of endemic stability (Norval et al., 1992). Infected male ticks were not used for 
transmission experiments as male ticks are not considered to be effective vectors. Female 
ticks from Batch 3 were selected for experimental challenge of cattle because they 
represented the largest proportion of the experimentally infected tick batch and exhibited the 
lowest infection levels among the female batches.  All experiments were carried out in 
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accordance with procedures approved by ILRI’s Institutional Animal Care and Use 
Committee, which insures adherence to internationally approved standards of animal welfare. 
Ten Friesian (Bos taurus) bull calves (six months of age), serologically confirmed to be 
free of infection with Babesia bigemina, Anaplasma marginale, T. parva and Theileria mutans 
according to ELISA were reared under tick-free conditions. Calves were split into two groups 
of five animals each, due to space constraints within the tick unit animal containment facility. 
Identification of bovine classical class I alleles (BoLA class I alleles) of each animal was 
determined by PCR amplification using Bov14 and Bov7 primers followed by cloning and 
Sanger Sequencing (described by Birch et al., 2006).  Classical class I alleles were identified 
by BLAST algorithm search against the cattle section of the Immuno Polymorphism Database 
(http://www.ebi.ac.uk/ipd/mhc/bola).  Results shown in Table 1 emphasize that a broad range 
of different BoLa class I alleles were expressed in experimental cattle.  Evidence suggests 
that the peptide-specificity of the CTL response to T. parva infected lymphocytes depends on 
the MHC genotype of the animal (reviewed in Norval et al., 1992).  
Thirty female T. parva infected RAM-L adults from Batch 3 were applied in a bag attached 
to the right ear of each calf. Thirty T. parva uninfected male Muguga ticks were placed in the 
same bag to facilitate the feeding of female ticks. Female ticks were allowed to feed to 
repletion and detach after which they were collected and removed. Blood samples from both 
the jugular and ear vein were taken daily following tick application. Daily lymph node biopsies 
were taken from day ten after RAM-L application from the local lymph node draining the site 
of infection (right ear), and from day 15 from the contralateral pre-scapular lymph node (left 
shoulder). Rectal temperature was recorded daily from the onset of the experiment. 
Transmission of T. parva sporozoites to calves was evaluated using microscopy, PCR and 
serology. Microscopy was performed using Giemsa stained lymph node aspiration smears 
and blood smears for the detection of macroschizonts and piroplasms, respectively. 
Macroschizont infected cells were graded as I, II or III with increasing levels of infection 
designated by a higher number. Piroplasms were counted as the number of infected 
erythrocytes in a total of 1 x 103 erythrocytes screened. PCR based detection of low schizont 
parasitosis/piroplasm parasitemia in peripheral blood was performed in duplicate targeting the 
p104 gene of T. parva (Skilton et al., 2002, Odongo et al., 2010). Antibodies binding to the T. 
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parva polymorphic immunodominant molecule (PIM) antigen were detected using ELISA 
(Katende et al., 1998).  Cattle serum samples for use in the PIM ELISA were taken 12 and 10 
weeks post tick challenge for groups 1 and 2, respectively.  
In nine out of ten animals, schizonts were detected in Giemsa stained regional lymph node 
biopsy smears.  In animal BF019, no shizont parastites were detected however, this animal 
was tested positive using PIM ELISA and p104 PCR.  In animal BF033, shizont parasites 
were detected in both regional and contra-lateral lymph nodes but duplicated p104 PCR 
results were negative although anti-PIM antibodies were detected in this animal (Table 2). 
Two animals were treated once with a short acting tetracycline formulation on days 20 and 22 
to reduce discomfort caused by a persistent fever. The schizont parasitemia in the regional 
and contra-lateral lymph nodes had already declined by days 20 and 22.  
The ability to withstand a homologous lethal challenge has been observed in animals 
recovered from primary T. parva infections (Norval et al., 1992). To verify that T. parva 
sporozoites had successfully been delivered by the RAM-L ticks and that T. parva specific 
immunity was induced, all animals were needle-challenged with a lethal homologous dose of 
T. parva Muguga stabilate. Two T. parva naïve calves of the same age and breed served as a 
control group for this experiment. Twelve (group 1) or ten weeks (group 2) after tick 
infestation, all animals were challenged with a 1 mL dose of 1:20 dilution T. parva Muguga 
(ILRI stabilate 3087) administered subcutaneously at the right parotid lymph node. The 
animals were monitored daily as described above for the RAM-L tick transmission 
experiment.  
Control group animals underwent severe ECF reactions requiring repeated oxytetracycline 
treatment to prevent death. One control animal was euthanized after the completion of the 
experiment (day 23 post challenge) due to persistent infection that did not resolve after 
treatment. Hence, the parasite dose delivered was lethal to naïve cattle, characterized by 
persistent high fever, presence of T. parva schizonts in regional and contra-lateral draining 
lymph nodes followed by high piroplasm parasitemia. Control animals were classified as 
severe reactors to needle challenge (Table 2). In contrast, the ten T. parva infected RAM-L 
exposed animals were immune to this lethal challenge including animal BF019 in which no 
schizonts were detected after tick challenge. Six and four animals were graded as non- 
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reactors and mild to mild/moderate reactors, respectively, using the ECF index (Rowlands et 
al., 2000). Schizonts were observed in the parotid lymph node draining the site of infection in 
two animals and were detected for one and two days, respectively. Schizonts were not 
detected in the contralateral lymph node of any of these animals and none required drug 
treatment. These data clearly show that the immune response(s) induced by infection of cattle 
with T. parva infected RAM-L were capable of preventing subsequent ECF development. 
Schizonts were controlled at early stage and spreading to the contra-lateral lymph node was 
not observed (Table 2).  
This is to our knowledge the first study undertaken to evaluate feasibility of using a 
laboratory tick strain, RAM-L, to reproducibly deliver T. parva sporozoites to a significant 
number of cattle. After tick challenge, all animals were exposed to T. parva sporozoites as 
indicated by the detection of anti-PIM antibody titers in serum and resistance to homologous 
lethal challenge. Importantly, the RAM-L ticks used here mimic the field situation of T. parva 
infection by R. appendiculatus, where the majority of individual ticks are uninfected or only 
lowly infected (Norval et al., 1992). Host-parasite interactions during and after delivery of T. 
parva by RAM-L can now be dissected at the molecular level, providing novel information with 
relevance to immune effector mechanisms induced in cattle following tick-mediated T. parva 
exposure in the field.  
The effects of exposure to the tick-vector on tick-borne pathogen transmission and 
parasite development have been investigated in other systems (reviewed by Wikel, 1999; 
Schoeler and Wikel, 2001). Transmission of pathogens should ideally be performed using the 
tick-vector, since needle challenge excludes the potential impact of the tick on the route and 
quantity of infective pathogens introduced.  Additionally, the potential modulatory effects of 
tick salivary gland molecules on transmission and disease progression are also eliminated 
(Wikel, 1999). Using the RAM-L challenge model, infectious sporozoites are transmitted to 
cattle over several days commencing roughly 72 hours after tick attachment (Konnai et al., 
2007). This is in sharp contrast to one-time needle inoculation using a large number of 
cryopreserved sporozoites. Additionally, most needle delivery experiments have also involved 
administration of oxytetracylcine in the ‘infection-and-treatment’ procedure with unknown 
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effects on the development of T. parva and modulation of immune reposes induced in the 
host (Di Giulio et al., 2009).  
When RAM-L tick infested animals were needle challenged with a potentially lethal needle 
dose of T. parva sporozoites, all animals were protected with no clinical signs of ECF 
detected. These data confirmed that all animals had been exposed to sporozoites and that a 
strong protective immune response against autologous re-challenge had been induced. It is 
well documented that under conditions of endemic stability T. parva does not result in high 
mortality rates (Norval et al., 1992).  Calves are believed to be partially protected by maternal 
antibodies with the recruitment of a cellular effector mechanisms resulting in strong immunity 
to re-challenge.  Repeated exposure to different parasite genotypes results in broadening of 
the spectrum of immunity and as a result, most adult cattle are immune to ECF under 
conditions of endemic stability (Norval et al., 1992).  
There are a number of novel ECF vaccine candidate antigens that require evaluation for 
their ability to induce protection using defined delivery systems. However, testing of subunit 
ECF vaccine candidates for ECF control, such as the major sporozoite surface antigen p67 in 
the field is costly and results are difficult to interpret being prone to a number of unpredictable 
confounding factors (Musoke et al., 2005). Natural tick population density varies considerably 
throughout the year and T. parva parasite genetic diversity circulating at field sites is 
considerable but not fully defined at vaccine trial sites prior to immunization. The general 
health status of the vaccinated cattle also influences the testing outcome (Norval et al., 1992, 
Musoke et al., 2005). The system currently employed for evaluation of vaccine candidate 
antigens uses a high number of sporozoites delivered simultaneously by needle challenge. 
This may result in prematurely discarding candidates that could be effective under field 
conditions due to unrealistic experimental conditions. This is particularly important given that 
theoretical analyses suggest that vaccine effectiveness in the field may be achieved with 
lower levels of laboratory efficacy than has traditionally been believed (Woolhouse, 1995). 
Further development of the RAM-L model, will allow the number of infected ticks applied to 
each animal to be adjusted to reach doses of sporozoites that are useful for vaccine testing. 
Although it was not possible to directly determine the absolute number of sporozoites 
delivered to each animal by RAM-L, the average exposure can be calculated statistically 
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based on the infection rates in the salivary glands of a selection of ticks derived from the 
challenge population. It is important to note that when using cryo-preserved sporozoites, the 
infective dose delivered is calculated prior to freezing of stabilates and the effect of freezing 
and thawing on both the number and metabolic activity of sporozoites remains unknown (Di 
Giulio et al., 2009).  
The leading malaria vaccine candidate (RTS,S) currently undergoing Phase 3 testing, 
underwent extensive preclinical and clinical evaluation prior to the current formulation of the 
vaccine. The development of a controlled human malaria infection model (CHMI) at Walter 
Reed Army Institute of Research (WRAIR)/Naval Medical Research Center (NMRC) was an 
integral and essential part of the RTS,S vaccine development program. The CHMI model 
facilitated step wise development of optimal dosing, adjuvant formulation and immunization 
regimens before moving RTS,S into costly field trials. Importantly, protection data derived 
from CHMI were highly predictive for results obtained later in field studies (reviewed by 
Ballou, 2009 and Sauerwein et al., 2011). Results using experimental vaccine candidates that 
showed little or no protection in CHMI have been very helpful in guiding the subsequent 
research agenda and for terminating projects that are unlikely to achieve field success in a 
timely and appropriate manner (Ballou, 2009). Similar approaches are currently actively 
developed and pursued in other infectious diseases including human influenza (Carrat et al., 
2008), tuberculosis (Minassian et al., 2011), Salmonella typhi (Levine et al., 2001) and 
dengue virus (Gunther et al., 2011).  
The newly developed RAM-L model can provide information under controlled conditions 
that mimic the field relating to the protective capacity of experimental subunit T. parva 
vaccines using substantially smaller animal numbers than conventional field trials. 
Additionally, the system will enable evaluation of combination vaccines (transmission blocking 
vaccines) targeting both the tick-vector and the parasite.  
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Tables and Figures 
Figure 1: Distribution of T. parva infection in RAM-L.  The parasites are present at low levels 
and occur in a minority of ticks within the population.  Infection rate is determined as the 
number of ticks of the sample population (n=30) containing T. parva infected acini. 
Abundance is the average number of infected acini per tick examined.  
CHAPTER 4: A CONTROLLED TICK TRANSMITTED T. PARVA INFECTION MODEL  
_________________________________________________________________________ 
89 
Table 1:  MHC classical class I allele typing of ten T. parva immune RAM-L tick challenged 
calves that were re-challenged with a lethal sporozoite dose demonstrating heterogeneity 
within the population. 
Animal Number Allele Group 
1 2 3 4 5 6 
BF008 2*03201N 3*05002 
2*03001 3*00402 
2*03202 3*00401 
BF009 2*02201 3*00201 
3*05101 
BF010 2*03202 3*06801 6*01501 
BF011 1*00902 3*01701 
BF013 1*00901 3*00402 4*02401 
BF014 2*02603 3*05002 
3*02702 
BF019 2*03201N 3*00201 4*06301 
2*04801 
BF023 1*01901 2*00801 6*01302 
BF027 2*01601 3*00201 5*06401 
2*01201 
BF033 1*02301 
1*04201 
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Table 2: Response to RAM-L and subsequent lethal needle challenge based on clinical 
observations combined with classification using the ECF index (Rowlands et al., 2000).  
Animal 
Number 
Reaction to RAM-L 
delivered sporozoites 
Reaction to lethal 
needle challenge 
BF008 Mild/Moderate reactor Mild reactor 
BF009 Mild reactor Non reactor 
BF010 Severe reactor Non reactor 
BF011 Severe reactor Mild/Moderate reactor 
BF013 Mild reactor Mild reactor 
BF014 Mild reactor Non reactor 
BF019 Mild reactor Non reactor 
BF023 Mild reactor Mild reactor 
BF027 Mild/Moderate reactor Non reactor 
BF033 Mild reactor Non reactor 
BF0071 - Severe reactor 
BF0181 - Severe reactor 
1 Needle challenge control animals naïve to challenge 
!
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Abstract 
Transmission blocking vaccines have been proposed for the control of many vector-
borne diseases and a commercially available transmission blocking vaccine for the control of 
the tick-borne human Lyme disease has been developed. Infection of cattle with Theileria 
parva results in the lymphoproliferative disease, East Coast fever which is associated with 
high morbidity and mortality rates in susceptible cattle. A number of tick antigens have been 
proposed as vaccine candidates for the control of the tick vector of T. parva, Rhipicephalus 
appendiculatus.  In this study, experimental cattle were vaccinated with a multivalent antigen 
cocktail containing the R. appendiculatus candidate antigens TRP64, histamine binding 
protein (male and female variants) and subolesin.  Also included in the vaccine cocktail was 
the T. parva antigen p67, which is located on the surface of sporozoite cells. Using a tick-
transmitted parasite model RAM-L, the effect of vaccination on the transmission of parasites 
to naïve susceptible calves was evaluated. All seven antigens in the cocktail induced a 
detectable antibody response. Establishment of disease in cattle was 20% lower in the 
vaccinated group indicating that the multivalent vaccine had a partial transmission blocking 
effect. Importantly, vaccinated cattle that did not show clinical symptoms of infection were 
protected from homologous lethal re-challenge.  This indicates that immunity to disease was 
induced.  These results suggest that transmission blocking vaccines for the control of East 
Coast fever should be further evaluated. 
Keywords 
Transmission blocking vaccine, Theileria parva, Rhipicephalus appendiculatus, p67, 
TRP64, subolesin, histamine binding protein, cattle 
Introduction 
Transmission blocking vaccines (TBV) aim to interfere with or block pathogen 
development within the vector responsible for pathogen transmission.  As a result of 
vaccination pathogen transmission to the vertebrate host is reduced. Transmission blocking 
vaccines are principally based on immunization of vertebrate hosts with antigenic structures 
derived either from the pathogen or the transmitting vector.  Transmission blocking vaccines 
can either block transmission from the vector to a vaccinated host or vaccination may inhibit 
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uptake of pathogens from an already infected host.  In the case of the latter, while the 
vaccinated host is not protected from pathogen infection no parasite transmission to 
additional susceptible hosts can occur.  Either approach may be a feasible strategy to reduce 
pathogen burden in endemic areas.  An effective TBV may need to combine different 
antigens as the cumulative effect of antibodies targeting several antigens may produce more 
efficient transmission-blocking effects (Duffy and Kaslow, 1997; Gozar et al., 1998; 
Kongkasuriyachai et al., 2004).  
During and after blood feeding, ticks are susceptible to antibodies and other modulatory 
molecules imbibed during the blood meal. If these antibodies induce disruption of gut 
integrity, interference of digestion may occur and the passage of infectious agents across the 
gut wall may also be affected. It is well known that repeated tick infestation results in local 
inflammation in vertebrate tissues that mediates resistance against ticks, probably through 
the pathways of delayed-type hypersensitivity. At the tick attachment site, a number of 
proteins molecules are secreted through the saliva into the skin of the host, including agents 
mediating host immune response suppression, blood anticoagulation and anti-inflammatory 
agents (Wikel, 1999; Bowman and Sauer, 2004). 
East Coast fever (ECF) caused by the protozoan parasite Theileria parva is considered 
the most devastating of tick-borne diseases affecting cattle in sub-Saharan Africa. 
Transmitted by the three-host tick, Rhipicephalus appendiculatus, infection results in high 
mortality and morbidity rates (Norval et al., 1992; Minjauw and McLeod, 2003; Bishop et al., 
2004). Currently, as with other tick-borne diseases of cattle, control of ECF relies primarily on 
acaricide treatment and the use of disease tolerant breeds. However, the emergence of 
acaricide resistance, environmental contamination concerns and costly infrastructure 
requirements pose significant challenges to their continued use. Although the infection-and-
Treatment immunisation method (ITM), involving a potentially lethal injection of live 
sporozoites in combination with a long acting formulation of oxytetracylcine is available, its 
large-scale deployment has been limited (Di Giulio et al., 2009). The development of a 
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sustainable control method for ECF remains critical for increased production in affected 
regions, particularly the small-holder cattle production system (Minjauw and McLeod, 2003).   
Immunization of cattle with recombinant subolesin protected cattle from Rhipicephalus 
(Boophilus) microplus infestation by decreasing tick survival and reproductive capacity 
(Almazán et al., 2010; Merino et al., 2011).  Additionally, subolesin was found to control tick 
gene expression, impact the tick innate immune response and decrease tick infection by tick-
borne disease pathogens Anaplasma marginale, Anaplasma phagocytophilum and Babesia 
bigemina (de la Fuente et al., 2006; Kocan et al., 2009; Galindo et al., 2009; Zivkovic et al., 
2010, Merino et al., 2011). The effect of subolesin on the biology of ticks has been 
demonstrated using RNAi resulting in degeneration of tick gut, salivary glands, reproductive 
tissues and embryos (de la Fuente et al., 2008; Nijhof et al., 2007; Almazán et al., 2005, 
Kocan et al., 2007; Almazan et al., 2010; de la Fuente et al., 2010).  A dual-action vaccine 
target TRP64, identified as a R. appendiculatus cement cone protein, acts both as an 
‘exposed’ antigen present in the saliva, as well as sharing ‘concealed’ antigenic epitopes 
within the tick midgut (Havliková et al., 2009). Vaccination with TRP64 has been shown to 
inhibit tick feeding as well as reduce levels of transmission of tick-borne encephalitis virus in 
mice (Labuda et al., 2006). Histamine binding proteins contained within the saliva are thought 
to play a role in controlling the itch-response of the host by sequestering histamine at the 
wound site competing with histamine receptors (Paesen et al., 1999).  Although not 
previously evaluated as an anti-tick vaccine candidate, R. appendiculatus histamine binding 
protein was able to prevent murine allergic asthma (Couillin et al., 2004). 
The T. parva antigen p67 is the major protein expressed on the sporozoite surface and 
has been implicated in the entry of parasites into lymphocytes. Results obtained from 
experimental p67 trials showed that vaccination could protect between 60 % and 70% of 
cattle from lethal sporozoite needle challenge (Musoke et al., 1992, Nene et al., 1996, Nene 
et al., 1999) however, evaluation under field challenge only resulted in a reduction of severe 
ECF cases by 30% (Musoke et al., 2005).  
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Herein, we describe the evaluation of a multivalent transmission blocking vaccine 
composed of a recombinant antigen cocktail of tick and parasite origin for control of ECF. 
The multivalent antigen cocktail included two female-specific and one male-specific R. 
appendiculatus histamine binding protein, an R. appendiculatus subolesin homologue, and 
the TRP64 cement protein (both full length and truncated 18-89 amino acids). Vaccinated 
animals were challenged using a selected tick line, RAM-L, which characteristically harbors 
low levels of T. parva infection similar to those found in areas of endemic stability (Young et 
al., 1995, Olds et al., manuscript submitted). This tick based experimental challenge was 
used to establish under simulated field conditions the T. parva transmission blocking effect 
and the anti-tick effect on a population of nymphal and adult R. appendiculatus ticks. 
Materials and Methods 
Vaccine antigen expression and purification 
Antigens selected to form part of the cocktail included p67C (Musoke et al., 1992), 
histamine binding proteins male (HBPM, AAC63108.1, Mr 22 kDa), female one (HBPF1, 
AAC63106.1, Mr 48 kDa) and female two (HBPF2, AAC63107.1, Mr 70 kDa) (Paesen et al., 
1999), TRP full length (TRPFL, AF469170.1, Mr 64 kDa), TRP truncated amino acids 18-89 
(TRP18-89, Mr 58 kDa) (Trimnell et al., 2002) and Subolesin (4D8, ABA62331.1, Mr 47 kDa).  
Subolesin was expressed with a GST tag, which was removed prior to vaccination of cattle. 
Recombinant tick antigens were expressed and purified by GenScript Corp., New Jersey, 
USA.  The production of p67 c-terminal  (p67C) in pQE30 was performed as described in 
Bishop et al (2003).  Due to the small size of p67C  (80 amino acids corresponding to 
approximately 10 kDa), size exclusion chromatography was used for purification. Briefly, the 
cell pellet was resuspended in 10 ml of LEW buffer (Pierce) with 1mg/ml lysozyme added, 
and sonicated. The supernatant fraction was loaded onto a CentriPor column (Spectrum 
Medical Industries) with a cut-off of 10 000 Da and treated according to manufacturers 
instructions.  The resulting protein was quantified using the Bradford protein assay with BSA 
as a standard.  
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SDS PAGE and immuno-blotting 
Protein expression and purification was confirmed by SDS-PAGE and immuno-blotting.  
Proteins resolved on SDS-PAGE gels were transferred to nitrocellulose membranes 
(Schleicher & Schuell, Dassel, Germany) for immune-blotting.  All incubation periods were for 
one hour at room temperature.  Immuno-blots were blocked using 5% skimmed milk in Tris-
buffered Saline with Tween 20 (TBST) (10 mMTris, 150 mMNaCl and 0.05% Tween 20), pH 
8.0 and all washing steps were carried out using TBST.  Following blocking, the membrane 
was washed, then incubated for one hour at room temperature in anti-his tagged antibody 
(Sigma).  Following a further washing step, blots were incubated with 1:5000 with anti-rabbit 
whole Ig linked to peroxidase conjugate (Amersham Biosciences) diluted in TBST.  After a 
final wash step, blots were developed using TMB substrate (Ingenasa) and the reaction 
stopped by rinsing the membrane in water.  Antigens were determined to have a purity of 
75% and above by SDS PAGE and coomassie blue staining. 
Vaccine formulation 
The seven antigens were split into two groups for vaccination to avoid antigenic 
competition between protein variants.  Group A contained HBPM, HBPF1, TRPFL and Group 
B included 4D8, HBPF2, TRP18-89 and p67C. Inoculation preparations contained 50 µg of 
each antigen with the final volume adjusted to one ml with phosphate buffered saline (PBS) 
pH 7.4.  Preparations were emulsified in an equivalent volume of Montanide ISA 50 V 
adjuvant (Seppic) mixed according to manufacturer´s instructions.  Control preparations 
consisted of one ml PBS emulsified in an equivalent volume of Montanide ISA 50 V adjuvant. 
Vaccine administration 
Thirty Bos tarus (either Friesian or Friesian/Ayeshire cross) calves, 3 months of age, 
were serologically tested to be free of tick-borne infections.  Calves were raised and 
maintained under strict tick-free conditions.  Calves were randomized into two groups (Group 
1 and Group 2), each containing ten vaccinated and five control animals. The two groups 
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were treated in an identical manner with a two-week separation between the two groups. 
Vaccinations were administered subcutaneously at the pre-scapular region with Group A 
antigens administered on the left shoulder and the Group B antigens on the right shoulder. 
Control preparations were split equally over the left and right sides.  Each animal received 
three inoculations separated by four-week intervals.  
Monitoring immune response to vaccination by indirect ELISA 
Immune responses directed against individual antigens were monitored for each animal. 
Ninety six -well plates (Polysorp, Nunc) were coated with 0.5 µg recombinant protein per well 
and incubated for one hour at 37 °C.  Plates were washed three times with PBS containing 
0.5% (v/v) Tween 20 (PBST) and blocked with 1% casein in PBST for 30 minutes at 37 °C. 
All wash steps were carried out using PBST.  Serum from trial animals was applied at an 
initial concentration of 1:500 and incubated for one hour at 37 °C.  After washing, secondary 
antibody (anti-bovine IgG, whole molecule, peroxidase conjugate, Sigma) was added at a 
dilution of 1:10 000 in PBST for one hour at 37 °C.  After the final incubation, plates were 
washed three times in PBST and given a final rinse in PBS. Plates were developed using 
SIGMAFAST OPD (Sigma) following instructions and signals were evaluated at optical 
density (OD) 405 nm.  Mean readings (with standard error) were calculated for each time 
point by grouping control and vaccinated animals.  Endpoint titers were determined as the 
last serum dilution where the OD of test sera was 2≥OD of negative control bovine serum 
donor.  Time points evaluated were before vaccination (day 0), two weeks after inoculation 
one (week 2), two weeks after inoculation two (week 6), two weeks after inculcation three 
(week 10).   
Theileriaparva tick challenge model: RAM-L 
Tick strains 
The R. appendiculatus Muguga ‘high-line’ and R. appendiculatus Muguga ‘low-line’ tick 
strains used for this study are both maintained at the International Livestock Research 
Institute (ILRI) Tick Unit.  The Muguga tick strain was collected from the central highlands of 
CHAPTER 5: TRANSMISSION BLOCKING VACCINES FOR ECF CONTROL 
_________________________________________________________________________ 
!!!!
98!
Kenya in the 1950s and propagated at the East African Veterinary Research Organization-
Kenya Agricultural Research Institute (EAVARO-KARI).  It was subsequently maintained as a 
laboratory stock at ILRAD/ILRI (Bailey, 1960). The differentiation of the Muguga strain into 
separate high- and low-lines involved the pooling of siblings from family lines with high or low 
susceptibility to infection (Young et al., 1995) and subsequent maintenance as separate 
stocks.  Uninfected ticks were maintained in Biological Oxygen Demand (BOD) incubators at 
28 ± 1 °C and ticks infected with T. parva at 24 ± 1 °C, 80% relative humidity.   
Theileria parva strain 
T. parva Muguga (stabilate no.3087) was originally isolated from the Kiambu District of 
Kenya after which it was maintained as a laboratory stock through tick passage (Bailey, 1960) 
and as tick derived stabilates (Radley et al., 1974; Dolan et al., 1984). 
Challenge of vaccinated calves with RAM-L challenge model 
Thirty adult T. parva infected RAM-L females were secured using an ear bag attached to 
the right ear of each calf.  Thirty uninfected male Muguga high-line ticks were placed in the 
same bag to facilitate the feeding of female ticks.  Within the population of ticks, 20% of ticks 
contained infected acini with the average number of infected acini per tick being 1.16.  Using 
30 female ticks, the probability of parasite transmission to a susceptible calf was p=0.99 
(Survival curve analysis, probability of transmission p=0.999, Therneau, 2012).  Ticks fed till 
repletion and detached, at which point they were collected and the animals removed from the 
facility.  Two weeks after the application of ticks to Group 1 calves, the Group 2 calves were 
treated in an identical manner.  The anti-tick effect of the vaccine preparation was measured 
on uninfected adult Muguga high-line female (n=50) and male (n=50) applied to the left ear. 
Additionally, 200 nymphal ticks were applied in a bag attached to the back of each animal.  
Adult female engorgement weight, adult female egg laying capacity, nymph engorgement 
weight and molting efficiency were measured. 
Animal monitoring and recording 
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Serum and peripheral blood mononuclear cells (PBMC) samples were taken every 
fortnight for the duration of the study.  Blood samples from both the jugular and ear vein were 
taken daily after tick application.  Daily lymph node biopsies were taken from day ten after tick 
challenge in the local lymph node draining the site of infection (right ear), and day 15 in the 
contralateral pre-scapular lymph node.  Calves were treated as required with short- 
(Copermycin) or long-acting oxytetracycline (Butalex). Rectal temperature was recorded daily 
from the onset of the experiment.  
Detection of T. parva transmission 
Transmission of T. parva parasites and the establishment of infection was evaluated 
using a combination of microscopy, PCR and serology.  Serology was performed daily on 
Geimsa stained lymph node aspiration smears as well as on blood smears for the detection of 
piroplasms.  Macroschizont infected cells were graded as I, II or III with an increasing 
intensity designated by a higher number according to Rowlands et al. (2000).  Piroplasm 
parasitemia was quantified as number of infected erythrocytes in a population of 1 x 103 
viewed and expressed as a log value. 
Blood samples taken from each calf two weeks after infection were used for DNA 
extraction using the QiagenDNeasy Blood and Tissue kit according to instructions.  The p104 
gene PCR parameters and the primers used in the primary PCR were as described 
previously (Skilton et al., 2002, Odongo et al., 2009, Odongo et al., 2010).  All reactions were 
preformed in 15µl volumes using 5 µl of DNA extracted from blood for the primary reaction or 
5 µl of the primary PCR reaction for the nested PCR reaction with 0.25 units of Taq DNA 
polymerase, (Promega), 1X PCR buffer (Promega), 200 mM of each dNTP (Promega) and 25 
ng of primers and 1.5 mM of MgCl2.  The final PCR products were visualized by UV trans-
illumination. 
Antibodies directed against the T. parva PIM antigen were detected using the PIM-ELISA 
(Katende et al., 1998).  Serum samples used for detection were taken 12 or 10 weeks post 
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tick challenge for Groups 1 and 2 respectively.  In cases where animals died or were 
euthanized, the last sample before death was taken. 
Following recovery from primary tick-delivered infection, all antigen-vaccinated calves 
from Group 1 and 2 were challenged with a lethal homologous dose of T. parva Muguga 
(stabilate no.3087).  Two naïve susceptible calves served as controls in order to confirm 
lethal dose delivery. Animal monitoring was carried out as described infection delivered using 
infected ticks. All experiments were preformed in accordance with procedures approved by 
ILRI’s Institutional Animal Care and Use Committee. 
Data Analysis 
Non-responding animals were defined as animals in which no symptoms of T. parva 
infection were observed.  Mild-reactors were defined as animals in which no symptoms of 
infection were observed other than pyrexia.  In Mild/Moderate-reactors, schizonts were 
observed in the regional lymph node of infection but not in contra-lateral lymph node and no 
piroplasms were observed in blood smears. Moderate-reactors included animals where 
schizonts were detected in both regional and contra-lateral lymph nodes but no piroplasms 
were detected in blood smears.  Moderate to severe reacting animals had detectable 
schizonts in both regional and contra-lateral lymph nodes as well as piroplasm infected 
erythrocytes.  Severe-reactors were defined as animals which died directly from infection or 
were euthanized (classification adapted from Rowlands et al., 2000).  For each animal, 
symptoms were recorded for the day of onset, duration and intensity of symptom (Rowlands 
et al., 2000).  Right parotid lymph node aspirates represented the regional lymph node 
draining the site of infection, the left pre-scapular lymph node represented the contra-lateral 
lymph node. Jugular vein blood was collected for piroplasm parasitemia.  Differences 
between groups were analysed with One-way ANOVA if the data was normally distributed.  
Where the data was not-normally distributed and could not be transformed Kruskal-Wallis 
analysis of variance was carried out (STATA, StataCorp LP).  Kaplan Meier survival curves 
were generated for time till onset of symptoms (GraphPad, GraphPad Software Inc.).  Two 
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animals from Group 2 were removed due to concurrent lung-worm infections exacerbating 
East Coast fever reactions. 
Results 
Vaccination and monitoring of animals 
Thirty Bos tarus calves, 3 months of age, were vaccinated three times at one monthly 
intervals with the antigen cocktail. In Figure 1, recombinant proteins used for vaccination 
expressed in E. coli separated by SDS-PAGE and stained with Coomassie blue are shown. 
The antigens were pure and exhibited at the expected molecular sizes.  Protein expression 
and purification was confirmed using western blot analysis. Each animal received a total of 
150 µg of each antigen over the three inoculations, formulated in Montanide ISA50V adjuvant. 
Serum samples were collected from the animals before vaccination and 2 weeks after each of 
the three vaccination events. All serum samples were stored at -20 °C until end of vaccination 
and then tested simultaneously in ELISA for reactivity against each individual antigen. 
Antibodies were induced in all vaccinated animals against all antigens inoculated while 
control animals remained negative (Figure 2).  
T. parva transmission by RAM-L tick line 
Two weeks after the final vaccination, the first group of 15 animals (ten vaccinated and 
five controls) was transferred into the tick unit animal containment facility. Thirty adult T. 
parva infected RAM-L females were secured using an ear bag attached to the right ear of 
each calf.  Thirty uninfected male Muguga high-line ticks were placed in the same bag to 
facilitate the feeding of female ticks.  Within the population of ticks, 20% contained infected 
acini with the average number of infected acini/dissected tick calculated as 1.16. The intensity 
of infection (percentage of infected ticks / average infection rate) was calculated as 5.8. As 
one infected acinus is sufficient to transmit T. parva to a susceptible Bos taurus animal 
resulting in ECF development (Young et al., 1983), using 30 RAM-L female ticks for each 
animal would be sufficient to transmit parasites to every calf in the study. Ticks fed till 
repletion and detached, at which point the ticks were collected and the animals removed from 
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the facility. The second group of 15 animals (10 vaccinated and 5 controls) was treated 
identically to the procedure described for Group 1.  
Transmission of parasites and the establishment of T. parva infection was evaluated 
using a combination of microscopy, PCR and serology. The animals were monitored daily 
through lymph node needle biopsies starting from day ten after tick application (regional 
lymph node draining site of tick application). From day 15 onwards the contra-lateral pre-
scapular lymph node aspirates were monitored by microscopy. Serum samples for anti-PIM 
ELISA were collected 12 and 10 weeks post tick application for Group 1 and 2, respectively. 
For T. parva DNA detection using p104 PCR, blood samples were taken from each calf two 
weeks after tick application. Parasite transmission occurred in all calves as indicated by 
detection of anti-PIM antibodies. In two animals (one control and one vaccinated animal), no 
parasites could be detected by p104 PCR analysis suggesting that even where parasites 
were not detected by PCR, exposure to T. parva had occurred based on anti-PIM antibodies 
(Table 1). 
Impact of vaccination of ECF development 
In comparison to the control group, the number of vaccinated animals developing 
schizonts in the regional lymph node was reduced (13 out of 18 animals compared to 9 out of 
10 control animals). This difference is presented in Figure 3B which shows the number of 
days to onset of schizont parasitosis. A measurable although statistically not significant effect 
of the vaccination was observed. Two of the five animals not exhibiting parasite establishment 
did not develop pyrexia and were classified as non-responders.  No non-responder animals 
were found in the control group.  Interestingly, once schizonts were detected in animals, ECF 
progressed at equal rate and intensity irrespective of the vaccination status of animals. No 
difference was observed between vaccinated and control animals for the time of duration and 
intensity of other symptoms. The spread of infection measured by the presence of schizonts 
in the contra-lateral lymph node, occurred in 61.5% of vaccinated animals and 67.5% of 
control animals (difference of proportions test, p=0.751). In animals with schizonts in the 
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contra-lateral draining lymph node, 62% of vaccinated animals and 60% of control animals 
went on to develop piroplasm parasitemia (difference of proportions test, p=0.917).  Following 
lethal challenge of vaccinated animals, only one animal exhibited the emergence of schizont 
parasites in the regional lymph node draining the site of infection (Table 2).  Parasites were 
detected at a grade of I, the lowest possible grade, and persisted for one day.  Roughly half of 
the animals showed no reaction to lethal needle challenge (non-responders) with remaining 
calves classified as mild-reactors showing only low grade, transient pyrexia.  This 
demonstrates that a protective immune response was induced in all vaccinated calves, most 
importantly in non- and mild-reactors.   
Anti-tick effect of multivalent vaccination of cattle 
To determine the anti-tick effect of vaccination on the biological fitness of R. 
appendiculatus adult and nymphal ticks, 50 adult and 2000 nymphal ticks were applied to ear 
and back bags of each animal for adult and nymph ticks respectively.  The results of 
vaccination on both adult and nymphal tick populations are shown in Table 3. No difference in 
adult female engorgement weight, egg-laying capacity, nymph engorgement weight or molting 
rates were seen indicating that vaccination had no effect on the feeding and reproductive 
capacity of R. appendiculatus ticks. No effect on direct mortality was noted between the two 
groups (analysis of variance, p= 0.2007) with an average of 47.8 adult females (SE=1.552) 
collected from vaccinated animals and 46.2  (SE=1.114) from control animals.  
Discussion 
Transmission blocking vaccines offer an avenue for vector-borne disease control in both 
humans and livestock. For control of Ixodes-transmitted Lyme disease, a TBV based on the 
Osp A protein of Borrelia burgdorferi has been developed and commercialized (LYMErix, 
SmithKline Beecham Biologicals).  Osp A has been shown to be essential for tick gut 
colonization, survival and development of spirochetes (Yang et al., 2004).  Vaccine induced 
antibodies against OspA results in transmission blocking to a future host.  While this 
approach does not protect the vaccinated host, it does inhibit transmission to a future 
CHAPTER 5: TRANSMISSION BLOCKING VACCINES FOR ECF CONTROL 
_________________________________________________________________________ 
!!!!
104!
susceptible host, hence these vaccines are described as ‘altruistic vaccines’.  For control of 
Plasmodium infections, the development of altruistic TBVs has been identified as an essential 
tool for reduction of transmission leading to malaria eradication (The malERA Consultative 
Group on Vaccines, 2011).  While a number of candidates have been evaluated, the furthest 
development has occurred with the Pfs25 protein homologues of P. falciparum and P. vivax, 
Pfs25 and Pfv25, respectively (reviewed in Coutinho-Abreu and Ramalho-Ortigao, 2010). 
Pfs25 is a 25 kDa protein expressed on the surface of the zygote and ookinete stages 
(Kaslow et al., 1988). The antigen has been successfully expressed, purified and formulated 
in Montanide ISA51 adjuvant. Phase I clinical trials have been carried out with this Pfs25 
formulation and the antibodies induced inhibited P. falciparum oocyst development in 
Anopheles stephensi by more than 90%, highlighting the feasibility of the approach. However, 
safety concerns prevented further development of this product (Wu et al., 2008).   
Transmission-blocking activity has been demonstrated in dogs vaccinated with the 
Leishmune® [surface molecule (FML)-vaccine]. The vaccine containing the Leishmania 
donovani fructose-mannose ligand in a sapononin adjuvant was not designed as a TBV. 
However vaccination inhibited L. donovani and L. chagasi procyclic promastigote-binding to 
dissected midguts of the Lutzomyia longipalpis.  Both rate and intensity of infection were 
significantly reduced in the vector. Notably, the effect was still pronounced a year after 
vaccination (Saraiva et al., 2006).  
To evaluate the potential of TBV for ECF control in cattle, a cocktail vaccine containing 
tick and parasite antigens was expressed, formulated for cattle vaccination and evaluated for 
efficacy under experimental tick challenge.  Vaccination with the multivalent cocktail 
significantly increased the number of animals not exhibiting detectable clinical signs and 
symptoms of ECF.   The response to infection with T. parva and ensuing disease severity is 
directly related to the sporozoite dose delivered (Jarrett et al., 1969; Radley et al., 1974; 
Dolan et al., 1984).  Using the vaccination were describe here, the transmission of parasites 
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is likely to have been curtailed, resulting in a lower sporozoite dose delivered to vaccinated 
calves.  
Increasing the proportion of mild-reactor animals is particularly attractive in areas where 
conditions of endemic stability persist or their creation is desired. This is particularly important 
for resource limited small-holder dairy farming systems, for example in Western Kenya and 
Uganda where there is currently little tick control.  Reducing disease severity in such systems 
is of great socio-economic importance as they contribute up to 80% of livestock related 
products in developing countries (FAO, 2012). Complete prevention of T. parva transmission 
in such systems are not suitable since it does not enable establishment of appropriate 
immune responses to infection and increases risk of ECF outbreaks associated with high 
mortality rates in older animals (Norval et al., 1992; Billiouw et al., 2002). This is of particular 
concern where cattle are held in close proximity to the natural reservoir of infection, the 
African buffalo.  Increasing the proportion of animals not developing disease symptoms while 
undergoing a primary infection allows animals to acquire resistance to future infection without 
experiencing the negative pathologic effects of disease. Cattle become resistant to 
subsequent challenge and gradually broaden their immune response through repeated 
exposure to heterologous parasite strains (Norval et al., 1992).  In our experiments, 
vaccination of calves increased the number of animals undergoing primary infection without 
exhibiting clinical disease symptoms.  Importantly, these calves developed an immune 
response equivalent in terms of protection from lethal challenge to calves that experienced 
moderate to severe symptoms of infection. It is common for animals with low schizont 
parasitosis to recover from infection and withstand lethal challenge (Eugui and Emery, 1981; 
reviewed in Norval et al., 1992).  Here we show that vaccinated calves not exhibiting any 
parasitosis still develop an immune response able to withstand lethal homologous challenge. 
None of the anti-tick effects demonstrated in small-animal models were mirrored in our 
experiment using the original host-vector system. The effect of vaccination with TRP64 was 
originally evaluated in Balb/c mice, in which transmission blocking activity was noted (Labuda 
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et al., 2006).  Vaccination with different length versions of TRP 64 resulted in a significant 
anti-tick effect on R. appendiculatus feeding from vaccinated guinea pigs.  Mortality, mean 
engorgement weight and egg-laying mass were all significantly affected (Trimnell et al., 
2002).  Cross-reaction between TRP 64 and other tick species was also exhibited in guinea 
pigs (Trimnell et al., 2005).  Despite the induction of high antibody titres to both variants of 
TRP64 in cattle, none of the above anti-tick effects could be reproduced. These findings were 
confirmed by a recently published data reporting the anti-tick effect of TRP64 in rabbits 
(Saimo et al., 2011).   
The observed differences in protection between these host-tick systems may be partly 
related to tick-antigen recognition by the host species. Tick components detected by the non-
natural host species may not be immunogenic in the natural host – tick system (reviewed by 
Steen et al., 2006).  It is generally accepted that for anti-tick vaccination to be effective, high 
antibody titres should be induced by vaccination (Willadsen, 2004). It is equally important that 
the conformation of the recombinant antigen is maintained in such a way that protective 
epitopes are identified by the vaccinated host.  It is also possible that we did not test the most 
effective tick antigen in this experiment, since there has been no systematic evaluation of all 
available tick derived vaccine candidates. 
Endemic stability for ECF is defined as stage of host-tick-pathogen interaction in which 
there is a high level of pathogen challenge experienced by cattle via infected ticks with an 
absence of clinical disease despite constant pathogen exposure. In adults, a high level of 
protective immunity is observed in the absence of clinical disease (Norval et al., 1992). 
However, it is unknown what level of infected tick exposure and individual tick-infection rates 
are required to achieve this stability in absence of costly interventions such as acaricide 
treatments. Currently, the assessment of endemic stability in tick-borne diseases rests on 
sero-prevalence studies (Jonsson et al., 2012). The fact that all RAM-L exposed animals 
developed anti-PIM antibodies and vaccinated animals were solidly protected against lethal 
sporozoite needle challenge supports the use of this ELISA for measurement of ECF 
endemicity status.   
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In summary, this vaccine trial highlights the potential role of transmission reducing 
approaches for ECF control in cattle and is the first large-scale experimental evaluation of a 
TBV using a natural tick challenge system resembling field conditions. Results obtained also 
underscore earlier observations that it is difficult to extrapolate results from experimental 
model host species and that anti-tick vaccine evaluation should therefore to be carried out at 
an early stage in the target host species. 
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Tables and Figures 
Figure 1:  Coomassie blue stained gel showing SDS-PAGE analysis of the purified 
recombinant antigens incorporated into the multivalent vaccine. Lane 1: histamine binding 
protein male variant (22 kDa); Lane 2: histamine binding protein female variant one (48 kDa); 
Lane 3: histamine binding protein female variant two (70 kDa); Lane 4: TRP 64 truncated 18-
89 (58 kDa); Lane 5: TRP 64 (64 kDa); Lane 6: Subolesin (47 kDa); Lane 7: p67C (10 kDa).  
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Figure 2:  Development of antibody titres against  vaccine antigens  prior to and post  vaccination. Time points 
are (day 0), two weeks after first immunization (week 2), two weeks after second immunization (week 6) and two 
weeks after third immunization (week 10). 
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Figure 3:  Kaplan-Meier curves for time of first onset of symptoms in vaccinated and control groups of cattle.  
A shows the onset of pyrexia, B shows the detection of schizont parasites in the regional lymph node 
draining the site of infection (right parotid lymph node), C shows the detection of schizont parasites in the 
contra-lateral lymph node (left scapular lymph node) and D shows the detection of piroplasm infected 
erythrocytes in jugular vein blood. 
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Table 1:  Development of East Coast fever symptoms in cattle vaccinated with the multivalent 
antigen cocktail after exposure to RAM-L T. parva infected ticks. 
Animal ID Pyrexia1
Regional 
lymph 
node 
parasitosis1
Contra-
lateral 
lymph 
node 
parasitosis1
Piroplasm1 p104PCR 
Positive 
PIM 
ELISA 
reading2
VACCINATED 
BF002 10 (2) POS 37 
BF003 POS 39 
BF005 17 (3) 14 (4) POS 34 
BF006 5 (12) 10 (1) POS 58 
BF012 6 (9) POS 42 
BF016 9 (8) POS 56 
BF017 10 (8) 14 (7) 16 (5) 17 (4) POS 58 
BF021 9 (11) 10 (9) 15 (6) 17 (4) POS 88 
BF025 16 (2) 18 (1) POS 27 
BF026 14 (1) 15 (3) POS 55 
BF028 3 (2) 16 (2) POS 25 
BF029 16( 5) 15 (4) 18 (1) POS 42 
BF030 POS 43 
BF031 15 (5) 15 (3) 16 (1) POS 30 
BF032 7 (9) 10 (4) 20 (1) NEG 21 
BF034 17 (1) 14 (6) 16 (4) 17 (2) POS 40 
BF035* 10 (4) 13 (2) 14 (1) POS 55 
BF037 6 (7) 14 (7) 16 (5) 17 (4) POS 55 
CONTROL 
BF008 15 (6) 15 (5) 18 (2) POS 77 
BF009 17 (4) 15 (3) 18 (1) POS 57 
BF010 9 (10) 12 (6) 16 (4) 17 (4) POS 78 
BF011 16 (6) 10 (9) 16 (5) 17 (4) POS 90 
BF013 2(1) 15 (3) 19 (1) POS 49 
BF014 14 (3) 20 (1) 16 (1) POS 59 
BF019 7 (5) POS 39 
BF023 16 (2) POS 28 
BF027 5(14) 13 (2) 16 (2) 18 (3) POS 27 
BF033 15 (1) 10 (2) NEG 30 
1 Values are displayed as the day of first detection (duration observed in days).  Where 
symptoms were not observed in an animal, no values are reflected. 
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2 The average Percentage Positive (PP) value over duplicate samples. The PP is calculated 
as the (OD of test/OD of strong positive) x 100 (Wright et al., 1993; Katende et al., 1998). 
* Animal BF035 died from sudden onset ECF symptoms on day 15 post challenge
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Table 2: Comparison of ECF severity in vaccinated calves after primary exposure to T. 
parvainfected RAM-L ticks and secondary exposure through lethal needle challenge.  All calves 
are protected from lethal homologous challenge. 
Animal ID Primary infection response1 Lethal challenge response1
BF002 Mild-reactor Mild-reactor 
BF003 Non-responder Non-responder 
BF005 Mild/Moderate-reactor Mild-reactor 
BF006 Mild/Moderate- reactor Non-responder 
BF012 Mild-reactor Mild-reactor 
BF016 Mild- reactor Non-responder 
BF017 Moderate/Severe-reactor Non-responder 
BF021 Moderate/Severe-reactor Mild-reactor 
BF025 Moderate-reactor Mild-reactor 
BF026 Mild/Moderate-reactor Non-responder 
BF028 Mild-reactor Non-responder 
BF029 Mild/Moderate-reactor Mild-reactor 
BF030 Non-responder Non-responder 
BF031 Mild/Moderate-reactor Mild-reactor 
BF032 Moderate-reactor Non-responder 
BF034 Moderate/Severe-reactor Mild-reactor 
BF035 Severe-reactor 2
BF037 Moderate/Severe-reactor Mild/Moderate-reactor3 
Control 1 Severe 
Control 2 Severe 
1 Response to T. parvainfection determined by clinical observations in conjunction with ECF 
index (Rowlands et al., 2000).  Non-responders showed no symptoms of infection while 
mild responders showed only mild fever and no visible parasitosis. 
2 Animal BF035 died of severe East Coast fever after tick exposure. 
3 Low grade schizont infected cells detected for one day 
CHAPTER 5: TRANSMISSION BLOCKING VACCINES FOR ECF CONTROL 
_________________________________________________________________________ 
!!!!
122!
Table 3: Evaluation of the effect of transmission blocking vaccination on the biological fitness of R. 
appendiculatus ticks.  No effect on any of the tick biological parameters were seen. 
Vaccinated Control P value 
Nymph 
Average weight1 1.2 (SE=0) 1.2 (SE=0) 1.0000 
Molting success2 5.1 (SE=3.45) 2.1 (SE=0.74) 0.3556 
Adult 
Number engorged 47.8 (SE=1.60) 46.2 (1.11) 1.0000 
Average adult 
engorgement 
weight 
0.5278 
(SE=0.238) 0.5477 (SE=0.0019) 0.1797 
Egg weight laid 
total 
13.37 (0.58) 11.45 (SE=0.86) 0.1132 
Average egg 
weight/tick 
0.3188 
(SE=0.0534) 0.2464 (SE=0.0304) 0.0679 
Un-hatched egg 
weight total 
2.22 (SE=0.17) 1.78 (SE=0.27) 0.2180 
Un-hatched egg 
weight/tick (%) 
17.48 (SE=1.74) 16.2 (SE=2.43) 0.9649 
1 Average weight of a population of 100 individuals 
2 Percentage of ticks failing to molt in a population of 100 individuals !
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Abstract 
Ticks serve as efficient vectors for the transmission of disease causing pathogens to 
both humans and animals.  As a result, significant efforts are made towards the control of 
ticks and tick-borne diseases.  The feeding of ticks in vitro provides a platform for a number 
of standardized assays with diverse and far-reaching applications for tick and tick-borne 
disease research.  Using silicone-based membranes, a number of tick species have been 
adapted to feeding in vitro including Rhipicephalus microplus, Amblyomma variegatum and 
Amblyomma hebraeum and Ixodes ricinus. The three-host tick Rhipicephalus appendiculatus 
is responsible for the transmission of Theileira parva to cattle resulting in the fatal 
lyphoproliferative disorder, East Coast fever.  We report here for the first time the adaptation 
of R. appendiculatus adult females to in vitro-silicone based membrane feeding. 
Introduction 
The feeding of ticks in vitro from artificial skin-mimicking membranes has a number of 
potential uses.  Currently, the tick colony maintenance requires regular tick feeding on 
experimental animals. This procedure is associated with pain for the animals. Using in vitro 
tick feeding the number of animals required for tick colony maintenance can be significantly 
reduced (Kröber and Guerin, 2007a). For the development of anti-tick vaccines, in vitro 
feeding allows initial investigations on the role of a potential anti-tick vaccine antigen in tick 
survival and reproduction. Titration of antibodies directed towards distinct tick antigens can 
be used to determine minimum levels required to induce tick damage. These assays could 
possibly lead to surrogate markers of protection for anti-tick vaccines. In addition, in vitro 
feeding enables antigen localization studies and elucidating the detailed mechanisms of 
protection through vaccination induced antibodies. High-throughput screening for acaricide 
resistance as well as identification of new acaricide compounds can be aided. Studies on 
transmission of tick borne diseases, tick saliva and cement cone constituents can be carried 
out more easily, cheaper and with more control compared to the expensive in vivo 
techniques.  
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Attempts to encourage ticks to feed from artificial membrane systems have been 
successful for a number of species.  Soft ticks (Acarina: Argasidae) with their short feeding 
times were the first to be adapted to in vitro feeding through Parafilm ® membranes (Hokama 
et al., 1987; Schwan et al., 1991; Rennie et al., 2000).  Compared to soft ticks, hard ticks 
(Acarina:Ixodidae) feed for a longer time periods and therefore adaptations in the 
experimental setup are needed. Feeding of hard ticks has been attempted using membranes 
derived from a number of sources including embryonated hen egg (Pierce and Pierce, 1956), 
bovine and rabbit skin (Kemp et al., 1975; Voigt et al., 1993), glue-impregnated Baudruche 
membrane (Waladde et al., 1991, Waladde et al., 1993, Waladde et al.,1995) and silicone 
based membranes (Kuhnert, 1996, Kröber and Guerin, 2007b). The silicone membrane 
feeding method described by Kuhnert and later modified by Kröber and Guerin has been 
successfully used to feed Rhipicephalus microplus, Amblyomma variegatum and 
Amblyomma hebraeum and Ixodes ricinus ticks (Kuhnert et al., 1995; Kuhnert, 1996, Kröber 
and Guerin, 2007b). Successful artificial membrane feeding of Rhipicephalus appendiculatus 
has been described by Waladde et al. using a biodegradable glue-impregnated Baudruche 
membrane. The transmission of T. parva piroplasm to feeding ticks has also been achieved 
using this approach (Waladde et al., 1991; Waladde et al., 1993, Waladde et al., 1995). 
However, using this method it was difficult to get reproducible levels of tick feeding at the 
ILRI tick unit. Here we attempted to adapt the silicone membrane method described by 
Kröber and Guerin for feeding of larval, nymphal and adult stages of R. appendiculatus 
(Kröber and Guerin, 2007b). Essentially, this method employs silicone membranes attached 
to the base of a cylindrical feeding chamber.  Ticks placed within the chambers are contained 
using a ventilated stopper.  The membrane is then immersed in blood contained within 
commercial six-well plates.  We report here for the first time, the successful feeding of R. 
appendiculatus adults from silicone membranes. 
Materials and Methods 
Membranes 
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The making of silicone membranes and feeding chambers was carried out as described 
previously by Kröber and Guerin (2007a; 2007b).  Briefly, a silicone RTV-1 Elastosil E4 
(Wacker) was mixed with silicone oil (Fluka) till a sticky 'frog grip' was achieved. To make the 
mixture more fluid for equal spreading, 150 g/kg−1 hexane was added.  The mixture was 
spread over 70 × 120mm lens-cleaning paper (Kodak) attached with adhesive tape to kitchen 
plastic film.  Silicone was spread thinly over the tissue by repeated scraping with a rubber 
ruler.  Membranes were left to polymerize overnight at room temperature.  The following day, 
membranes were measured and uniform selections between 60 and 120 µm were cut to fit 
the feeding chambers.  Membranes were attached using Elastosil E4 silicone glue (Wacker).  
To provide additional attachment stimuli, glass fiber 1.4 mm mesh mosquito netting was 
glued to the membrane with silicone glue.  A 2 mm thick tile spacer was placed inside the 
chamber resting above the membrane to create additional borders for tick attachment.  The 
Perspex feeding chambers, netting and tile spacers were kindly donated by Patrick Guerin. 
An alternative Biobrane (Smith & Nephew) membrane was evaluated for its ability 
support tick feeding.  The Biobrane membrane was created to mimic the elasticity of skin for 
the treatment of burn wounds and is made of silicone membrane bonded to a nylon mesh to 
which peptides from a porcine dermal collagen source have been bonded to the nylon 
membrane to form a flexible membrane (http://global.smith-
nephew.com/master/BIOBRANE_27563.htm).  No alterations to the membrane were made 
other than sealing perforations with silicone glue.  Scent attachment stimuli were added and 
ticks covered with hair as before.  Tile spacers were also added to the chambers before tick 
application. 
Bovine blood preparation 
Blood was collected from donor bovine maintained under strict tick-free conditions since 
birth.  Blood was collected using three anti-coagulation methods to determine the effect of 
anticoagulant choice on tick feeding.  Blood was collected in heparin or ethylenediamine 
tetraacetate (EDTA) vaccutainer tubes or through manual defibrination by stirring with a 
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stainless steel spoon.  For manual defibrination, blood was stirred with a till a large blood clot 
was formed around the spoon.  The blood clot was removed and remaining blood 
supplemented with 2 g/L glucose (Sigma) to stabilize erythrocytes and stored at 4 °C till use. 
A portion of the blood was stored at -20 °C to evaluate the effect of blood freezing on tick 
feeding.  Prior to adding to feeding wells, gentamycin solution (5 µg/mL) and ATP (10−3 mM) 
was added to blood warmed to 37 °C.  Blood was changed at 12-hour intervals where 
agitation was not employed and every 24 hours where agitation was employed during tick 
feeding.  During blood changes, tick chambers were cleaned of execs fecal matter and the 
outside cleaned with saline solution.  Feeding plates were placed in biological oxygen 
demand incubators at 37 ± 1°C with 80% relative humidity. 
Bovine blood mixing 
Blood contained within the feeding wells was either continuously mixed through stirring 
or left to settle by gravity. Where blood mixing was employed, a small magnetic stirrer bar 
was placed on the base of the well of the six well plate.  The chamber was then suspended 
above the stirrer bar to allow free rotation of the stirrer bar.  The conventional six well plate 
could not be used to feed more than one chamber where stirring was employed as magnetic 
bars interfered with each other. In this case, a new blood chamber was developed. 
Rectangular containers were made from Perspex by the ILRI engineering department with 
depth of 3 cm, length of 20 cm and width of 12 cm.  A cover plate with 6 holes the diameter 
width of the feeding chamber was made to fit securely over the blood reservoir container.  A 
maximum of six chambers were then immersed in the same blood reservoir. In cases where 
fewer feeding chambers were needed, additional holes were covered in Parafilm to prevent 
air contamination of the blood. A magnetic stirrer bar was then placed as centrally as 
possible between feeding chambers. 
Testing of tick feeding stimuli 
Bovine and rabbit hair was evaluated for its ability to facilitate tick feeding.  Hair was 
clipped from animals not exposed to acaricides. Hair extracts were produced from bovine 
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and rabbit hair by chopping hair into 1 cm lengths. Methanol (200 mL) was added to hair and 
stirred for twenty minutes.  After stirring, extract was removed and stored in aliquots at -80 
°C.  An African buffalo ear-wash scent extract (produced previously by S. Mwaura) was also 
evaluated in this context. The effect of tick fecal matter on attachment and feeding was 
evaluated through application of fresh fecal matter to the membrane immediately prior to tick 
application. This fecal matter was collected from adult R. appendiculatus ticks feeding on 
rabbit ears during routine colony maintenance. 
Rhipicephalus appendiculatus ticks 
R. appendiculatus ticks used for all feeding experiments were from the laboratory 
Muguga-high line stock. The Muguga tick strain was collected from the central highlands of 
Kenya in the 1950s and propagated at the East African Veterinary Research Organization-
Kenya Agricultural Research Institute (EAVARO-KARI).  It was subsequently maintained as a 
laboratory stock at ILRAD/ILRI (Bailey 1960, Young et al., 1995). Different adult male to 
female ratios were investigated with a maximum of ten adult ticks added to the chamber.  
Female and male ticks were always added simultaneously.  Where larval or nympal stages 
were evaluated, storage vials containing ticks were placed at 4 °C for 2 minutes.  Once 
chilled a spatula was used to remove and add a scoop of larval or nympal ticks to each 
chamber. Adult ticks were stimulated before application by gently breathing over the vial 
before addition to the chamber. Our Muguga tick lines no longer have a diapause cycle and 
can be maintained in incubators without light.  
Results and Discussion 
Membrane thickness and continuous mixing of blood were discovered to be essential to 
the feeding of R. appendiculatus ticks in vitro.  When ticks were applied to the thicker 
membranes (120 µm), adult ticks were seen to probe the membrane repeatedly within the 
first hour of application. After this initial period no further attempts to attach and feed were 
observed and ticks quested to the top of the chamber. Membranes of 100 µm or less was 
determined as the best for supporting adult tick attachment and feeding.  Commercial 
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membrane Biobrane was found to be too elastic to be attached to chamber with tightness 
sufficient for tick perforation. The shore hardness of membranes is known to play a role in 
successful tick feeding in vitro (Kröber and Guerin, 2007b) and it is possible that this 
parameter was not met by the commercial membrane.  Although Waladde showed that ticks 
would feed from heparinized blood (Waladde et al., 1993), we found that R. appendiculatus 
ticks fed only from manually defibrinated blood.  Heparinized blood has a strongly metallic 
smell after incubation and it is possible this smell was unappealing to ticks.  Defibrinated 
blood from frozen stocks was also not accepted for feeding possibly due to a change in taste 
due to the rupture of erythrocyte with freezing.  The ratio of male to female ticks was also 
seen to be important.  An equal ratio of five males to five females per chamber was best for 
female feeding and engorgement.   
Separation of blood into a bottom erythrocyte layer and a covering serum layer occurred 
within hours of application to the six-well plate. Once separation occurred, ticks stopped 
feeding and detached from the feeding site.  Small cement cones were noted on the bottom 
of the membranes even though ticks were no longer feeding, indicating that attachment did 
take place for a short time.  We have observed that one factor essential for tick feeding is the 
requirement to have blood continuously mixed for extended feeding to occur. However, the 
use of a magnetic stirrer is not very practical as it requires a magnetic stirrer apparatus to be 
placed within the incubator.  Additionally, due to the magnetic interactions, only one stirrer 
can be used per plate.  This does not allow multiple chambers with variations to be 
investigated simultaneously.  An alternative method is to connect the blood chamber to a 
peristaltic pump which may better facilitate blood movement. 
Using agitated blood, attachment and feeding occurred for all female adult ticks and a 
full engorgement in 40% of female ticks was observed.  Although this is lower than would be 
achieved in vivo, it relates directly to the size of the feeding chamber.  Two engorged female 
ticks fill the space of the feeding chamber and as a result, there is little space for remaining 
females to engorge.  Importantly, female ticks that engorged fully weighed between 400 and 
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230 mg; this is comparable with tick feeding engorgement weight from a natural host. 
Female ticks engorging first were found to be up to double the weight of later engorging 
females, highlighting the possible effect of space constraints on female tick engorgement 
weight.     
When adult ticks attached and feed, they were very sensitive to changes in the 
environment.  Ticks showed signs of agitation with removal of the hair covering and cleaning 
of the chamber.  Attached ticks showed leg movement and attempts to detach from the 
membrane.  Free ticks began to quest to the top of the chamber.  Adult male ticks could 
never be seen attached to the membrane and feeding even when continuous mixing of blood 
was employed. This is not unusual as it is known that adult male feeding is sporadic.  Where 
female ticks did attach and feed, male ticks were observed in close proximity to female ticks. 
Male ticks died within a couple of days of addition to the chamber possibly after completion of 
mating.  Interestingly, where no female feeding occurred, male ticks did not die within the 
week period of evaluation.  The best ratio of five adult female to five adult male ticks resulted 
of full female engorgement. With a higher male to female ratio of eight males to two females, 
no female engorgement occurred although feeding did take place.  Female ticks fed over a 
period of ten days and rapid engorgement occurred over the last 48 hours (over days 8-10). 
Interestingly, this in vitro feeding took longer than the average period in vivo that is usually 
between five and seven days. Figures 1 to 4 show adult tick feeding results. 
Evaluation of feeding stimuli showed that bovine hair combined with bovine hair extract 
was superior to rabbit hair and rabbit hair extract for encouraging tick feeding.  The 
application of fecal matter had no impact on the rates of tick attachment nor did buffalo ear 
wash scent extract.  Larval and nymphal R. appendiculatus showed no interest in in vitro tick 
feeding. It is possible that even the thinner membranes were still to thick for them to 
successfully feed.  Additionally, larval ticks could not be contained within the feeding 
chambers and escaped through the mesh stopper.   
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Conclusion 
Although successful feeding of R. appendiculatus was ultimately achieved, the current 
technique is not as robust as has been reported by Körber et al (2007a, 2007b).  The hand 
made production of membranes is difficult and membranes that are not uniform or do not 
have the desired thickness are unsuitable to support tick feeding. The current dimensions of 
feeding chambers do not allow for feeding more than five adult females with space for only 
two ticks to engorge fully at any given experiment making statistical analyses difficult. An 
option of making larger chambers was explored but has not been successful due to the 
uneven membrane thickness that was produced by us. The prevention of blood separation 
into its components due to gravidity has to be addressed. 
We have explored here thoroughly the variables influencing in vitro feeding success of 
R. appendiculatus. Clearly, refinement of the current method will lead to improved success 
rates of R. appendiculatus feeding. This feeding technique will open avenues for vaccine 
development, acaricide testing, biological investigations and reduction of animal 
experimentation. 
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Figures 
Figure 1.  Feeding chamber after addition of fresh blood on day thee after tick application. 
The chamber on the left was modified to have a magnetic stirrer bar placed beneath the 
membrane. No questing ticks are seen on top of the chamber as attachment and feeding 
took place. On the right chamber, tick feeding without blood stirring is attempted. Questing 
ticks can be seen that move into the top part of the chamber. In the right chamber, no tick 
attachment and feeding occurred.   
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Figure 2:  Top view onto a chamber in which successful tick feeding after three days of 
incubation. 
After three days, if attachment was successful, ticks were disturbed as little as possible 
to allow for complete feeding and engorgement. Fresh fecal matter can be clearly seen 
particularly where feeding ticks are observed.  Successful tick attachment and feeding 
occurred at the wall of the feeding chamber (upper and lower right quadrants).  A dead tick 
can be seen at the bottom left quadrant (marked with a star). 
Tick fecal 
matter
*
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Figure 3 Result of tick feeding when testing a 100 µm tick silicone membrane without blood 
stirring after three days.  
One female tick showed partial feeding, shown attached in the upper right quadrant, 
although compared to stirred feeding females less advanced by the same time point.  This 
tick was irritated by removal of hair cover and detached shortly hereafter.  It failed to reattach 
and feed to repletion.  Dead ticks can be seen in the lower left quadrant (marked with stars). 
*
*
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Figure 4:  A 400 mg female tick engorged after feeding on 100 µm silicone membrane with 
blood stirring.  Not all females within the chamber have space to fully engorge as this female 
did, most likely due to space constraints. This in vitro fed female tick went on to lay roughly 
200 mg of eggs which hatched into viable larvae. 
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Introduction 
Animals recovering from primary T. parva infection are immune to lethal autologous 
challenge with up to 5 x 108 schizont infected cells (Eugui and Emery, 1981). Antibody 
responses are induced upon T. parva infection to sporozoite parasites but their involvement in 
protection from infection is unclear.  Transfer of sera from ECF immune to naïve animals 
does not protect against fatal ECF (Norval et al., 1992 Muhammed et al., 1975). This does 
not necessarily preclude a role for humoral immune responses in protection. Repeated 
infestation of cattle and rabbits with ticks infected with T. parva induced antibodies 
neutralizing sporozoite infectivity in vitro (Musoke et al., 1982).  Antibodies targeting the 
sporozoite surface antigen p67 have been explored extensively as a potential subunit vaccine 
candidate against ECF (reviewed in McKeever and Morrison, 1998). 
The effector mechanism for protection against T. parva infection is mediated through 
parasite-specific CD8+ T cell responses targeting schizont infected lymphoblasts (Eugui and 
Emery, 1981, Goddeeris et al., 1986, Morrison et al., 1987). This immune response has been 
studied in great detail and is reliably induced in cattle after inoculation of cryopreserved 
sporozoites. Large numbers of parasite specific cytotoxic T lymphocytes (CTLs) are 
generated in the lymph node draining the sporozoite inoculation site. At the height of the 
immune response, 1 in 30 T cells leaving the infected lymph node via the efferent lymph 
vessel are parasite specific CTLs (McKeever et al., 1994).  These CTLs proliferate in vitro in 
the presence of autologous schizont infected cells and respond with parasite specific killing 
activity (Pearson et al., 1979, Eugeui and Emery, 1981). While the initial CTL response 
observed in primary infection with T. parva requires input from activated parasite specific 
CD4+ T helper cells, in immune animals, the CTL response can be recalled in vitro in the 
presence of T cell growth factors or CD4+ T cells responding to unrelated antigens (Taracha 
et al., 1997).   
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Parasite specific CD8+ T cell responses are directed towards cells displaying T. parva 
derived peptides bound to Class I MHC molecules on the surface of schizont infected cells 
(Emery et al., 1981; Morrison et al., 1987).  Evidence suggests that the peptide-specificity of 
the CTL response depends on the MHC genotype of the animal.  In most cases, the response 
is restricted by one haplotype and certain biases for haplotypes exist (Goddeeris et al., 1986; 
Goddeeris et al., 1990, Taracha et al., 1995).  As a result, it is thought that the immune 
response to T. parva is limited to a set of immune-dominant peptide-MHC determinants 
(MacHugh et al., 2009, Taracha et al., 1995). All experiments inducing experimentally T. 
parva specific immune responses have been performed with isolated sporozoite infected 
animals. However, T. parva specific immune responses elicited in cattle after exposure to T. 
parva infected ticks have not been studied in any detail. We have established recently a 
reliable tick-based infection model for T. parva in cattle. These animals developed strong ECF 
protective immunity and investigations into the nature of the elicited immune response and 
their comparison to needle challenged animals have become feasible. Peripheral blood 
mononuclear blood samples taken from cattle before and after exposure to T. parva infected 
ticks were evaluated for their parasite specific CTL activity. 
Materials and Methods 
Animals 
Samples evaluated for the following study were taken during the RAM-L challenge model 
evaluation (Chapter 2).  Animal BB007 was used as a positive control.  This animal was 
infected with a lethal dose of T. parva Muguga coupled with oxytetracycline treatment seven 
years ago.  Once recovered, BB007 has been repeatedly challenged to maintain immunity. 
This animal reliably exhibits CTL activity in vitro. 
Isolation of peripheral blood mononuclear cells (PBMC) 
Isolation of PBMC from whole blood was carried out for each animal before tick 
exposure, two months after tick exposure and 28 days post homologous lethal needle 
challenge.  Animals BF007 and BF018 were sampled at day 28 post needle infection only. 
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Thirty mL of blood was bled from the jugular vein of each calf into an equivalent volume of 
Alsever’s solution.  PBMCs were extracted using a process of Ficoll-Paque layering (Ficoll-
Paque PREMIUM, GE Healthcare) and centrifugation.  Erythrocytes were lysed by incubation 
with Tris-ammonium chloride buffer at 37 °C for 5 minutes.  Remaining cells were washed a 
minimum of three times in 50 mL of Alsever’s solution and collected by centrifugation till a 
white pellet was formed.  The final pellet of PBMCs were resuspended in 2 mL of 10% DMSO 
in HyClone Fetal Bovine Serum (Thermo Scientific) and stored under liquid nitrogen till used.  
Infection of PBMCs with T. parva sporozoites to create infected lymphoblast cell lines 
PBMCs taken before exposure of calves to either tick or needle delivered T. parva 
sporozoites were infected with Muguga 3087 dissected salivary gland stabilate 4240.  Cells 
were infected using the method described by Goddeeris and Morrison, by incubation at 37 ° C 
for 1.5 hours with agitation every 20 minutes (Goddeeris and Morrison, 1988).  T. parva 
lymphoblast lines were maintained in tissue culture medium (HEPES buffered RPMI 1640 
supplemented with 10% heat-inactivated fetal calf serum, 2 mM L-glutamine, 100 units/ml 
penicillin, 50 ug/ml streptomycin, and 5 x 10-5 M β-mercaptoethanol), incubated at 37 C with 
5% CO2.   
Concavalin A (Con A) stimulated lymphoblast cell lines 
To establish continually growing Con A autologous cultures to serve as negative 
controls, pre T. parva challenge PBMCs were thawed and seeded at a density of 2 x 106 / mL 
into 24 well plates with tissue culture media supplemented with 10 ug/ml Con A.  Cultures 
were left to proliferate and maintained through splitting and feeding with tissue culture media 
supplemented with 5% T cell growth factor (TCGF). 
Cytotoxic T Lyphocyte assay 
Potential killing activity was investigated for two time points in RAM-L exposed calves 
BF011 and BF012, after tick infection and day 28 post lethal needle challenge.  In animals 
BF007 and BF018, one time point, 28 days post needle challenge was evaluated.  CTL 
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activity was measured using the standard 4 h-51Cr-release assay (Goddeeris and Morrison, 
1988).  Effector cells underwent two rounds of stimulation with Cesium-137 irradiated 
autologous TpL lines separated by seven-day intervals. Primary and secondary bulk 
stimulations were cultured in RPMI 1640 media supplemented with 10% heat-inactivated fetal 
calf serum, 2 mM L-glutamine, 100 units/ml penicillin, 50 ug/ml streptomycin, and 5 x 10-5 M β 
-mercaptoethanol with the addition of 5% TCGF.  One week following the second stimulation, 
chromium release assays were carried out with the highest starting dilution feasible.  Positive 
control for the assay was represented by T. parva Muguga immune animal BB007 which has 
shown reproducible killing activity in this assay.  Negative controls for each animal were 
represented by autologous ConA lyphoblast cultures. After incubation of effectors with Cr 
labeled targets, supernatants were transferred to Lumaplates (PerkinElmer, Waltnham, MA, 
USA) and counted using a TopCounter machine (PerkinElmer, Waltham, MA, USA). The 
cytotoxicity was calculated as experimental release-spontaneous release/total release-
spontaneous release. 
Flow cytometry 
To identify cell populations after stimulation with autologous TpL lines, samples were 
stimulated twice, seven days apart as for CTL assay preparation.  Time points analyzed were 
after tick infection and 28 days post lethal needle challenge from animals BF019, BF025, 
BF031 and BF033 were used for the analysis.  To determine the cell populations present after 
two rounds of stimulation, flow cytometry was carried out on a FACSCanto flow cytometer 
(Becton Dickinson).  Cell populations were labeled by incubation on ice for one hour with 
monoclonal antibodies able to identify different cell populations.  Primary antibodies included 
MM1A (CD3), IL-A11 (CD4), IL-51 (CD8), GB21A (Gamma Delta T cells), (T cells) and IL-A30 
(B cells) (Neassens et al., 1997).  Following washing, cells were incubated with appropriate 
FITC conjugated secondary antibodies. 
Results and discussion 
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The CTL activity in calves was evaluated at two time points.  The primary infection was 
induced through the feeding of RAM-L ticks (described in chapter 4).  Two months post tick 
infection, after calves had fully recovered from infection, PBMC samples representing ‘after 
tick infection’ were collected.  Calves were then challenged with a lethal needle sporozoite 
dose (1:20 T. parva Muguga, stabilate 3087).  PBMC samples were taken 28 days following 
lethal needle challenge representing the ‘after needle challenge’ time point.  PBMC samples 
were isolated, frozen and stored in liquid nitrogen until animal experiment had been finalized. 
PBMC of all freezing time points were thawed and re-stimulated in vitro using autologous T. 
parva infected lymphoblast cell lines. The expansion of effector cells was unreliable and 
required supplementation of cultivation media with T cell growth factor. In vitro proliferation of 
re-stimulated cultures to reach sufficient cell numbers for CTL assays was still rarely 
achieved. Where sufficient cell numbers were produced as in animals BF007, BF011, BF012 
and BF018, no specific chromium release was measurable (Figure 1, rows 1-3).  
This negative result led us to determine the effect of PBMC storage in liquid nitrogen on 
performance of cells in CTL assays. Therefore, PBMC from animal BB007 were isolated 
freshly and re-stimulated in vitro. Aliquots of the same PBMC were frozen down in liquid 
nitrogen. The negative impact of freezing on in vitro cell expansion and CTL activity is shown 
in Figure 1 row 4.  Killing activity was observed in freshly isolated and re-stimulated PBMC 
but not in recovered frozen cells. Hence, no conclusion on the induction of CTL activity in 
animals exposed to tick-delivered T. parva sporozoites can be drawn at the moment. 
Currently, novel cattle experiments are planned specifically addressing this question.  
To determine the phenotype of cells proliferating after in vitro re-stimulation in the 
presence of TCGF, flow cytometry analysis after antibody staining was performed. After two 
weeks of cultivation, the number of viable cells varied between different samples. No single 
lymphocyte subset dominated the cell culture as shown in Figure 2.  
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Conclusions 
Studies of the effector mechanisms and the antigens targeted in protective immune 
responses to T. parva are based on animals treated with needle administered sporozoites. 
This artificial method whereby a lethal dose of parasites is administered in a single inoculation 
may not represent an accurate reflection of the field situation, particularly in endemic regions 
where young calves experience low level primary parasite inoculations. The antigens targeted 
in these animals are most likely good subunit vaccine candidates since they exist under 
natural re-challenge situation. In our view, it is imperative to analyze the cattle immune 
response developed against T. parva under natural tick challenge. 
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Figure 1:  CTL from tick- and needle-based T. parva challenge in animals tested in 51Cr-
release assay.  Effector: Target (E:T) ratios are indicated for Muguga infected autologous 
PBMC. 
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Figure 2A: Proportion of stained B cells of total population.  A larger proportion of B cells were 
noted for animal BF031 both after tick and needle challenge.  
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Figure 2B: Proportion of stained Gamma Delta T cells of total population. 
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challenge 
Figure 2C: Proportion of stained CD4+T cells of total population.  BF033 showed a higher 
proportion of CD4+T cells. 
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Figure 2D: Proportion of stained CD8+T cells of total population.  BF033 showed a higher 
proportion of CD8+T cells similar with CD4+ T cells. 
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Livestock have been intricately tied to the livelihoods of humans since their 
domestication eight to ten thousand years ago (Mignon-Grasteau et al., 2005).  Nowhere is 
this connection currently stronger than for the rural small-holder, cash impoverished farmers 
and pastoralists who produce up to 90% of livestock products in countries of the South (FAO, 
2012).  Food and nutritional security are provided by livestock, which are able to convert 
vegetation from non-arable lands, crop residues and other household byproducts to high 
nutrient density food products.  Livestock can increase crop production by acting as a source 
of manual labor and by providing manure-based fertilizer. They serve as a cash reserve able 
to mitigate fluctuations in crop production, unfavorable weather conditions and pricing.  If 
allowed to breed, where sufficient grazing is available, livestock may even serve as an 
investment strategy.  Increasing the herd or flock size allows extra animals to be sold and the 
proceeds funneled into areas such as healthcare and education of children.  Livestock are 
considered gender equalizers as women who are not allowed to own or inherit land may in 
many cases be permitted to benefit from owning and selling livestock.  Livestock also form an 
important part of many ceremonies such as marriage and coming of age celebrations where 
they may be used as exchange of property and status symbol (Minjauw and McLeod, 2003; 
IUCN, 2011; FAO, 2012).   
Increasing livestock productivity is a key component of improving the quality of life of the 
poor and extremely-poor populations globally (FAO, 2012).  Additionally, in global agriculture, 
a livestock revolution is underway that has profound implications for human health, livelihoods 
and the environment worldwide. Population growth, urbanization and income growth in 
developing countries are driving a massive increase in demand for animal based food 
products. Ticks and tick-borne diseases are considered to be the largest impediment to 
increased livestock production (Minjauw and McLeod, 2003; Jongejan and Uilenberg, 2004). 
Ticks affect roughly 80% of the world’s cattle population and effective tick and tick-borne 
disease control is imperative for increased and sustainable livestock production to take place 
(McCosker, 1979; Minjauw and McLeod, 2003; Jongejan and Uilenberg, 2004).  Of the tick-
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borne diseases affecting cattle, East Coast fever (ECF), is the most devastating. ECF is 
caused by T. parva, transmitted by the brown ear tick R. appendiculatus and affects regions 
in East and Southern Africa. It has been estimated that ECF results in the death of over a 
million animals annually (Mukhebi et al., 1992). Current methods of ECF control are far from 
adequate and as with other tick species, the control of R. appendiculatus ticks through 
acaricides is becoming less and less sustainable. Although the Infection-and-Treatment 
method of live vaccination against ECF exists, adoption has been poor and is geographically 
limited. Sub-unit vaccines, particularly those targeting the pathogenic schizont stage of the 
parasite have been proposed, although, they are unlikely to be delivered to farmers in the 
immediate future.   
One important factor that should be taken into account is that ECF is distributed widely 
throughout East Africa, simultaneously affecting markedly different types of agricultural 
production systems. These systems have different needs for tick and tick-borne disease 
control and as a result, effective control strategies may differ substantially. Large-scale 
farming systems would benefit from an integrated pest management approach of anti-tick 
vaccination coupled with limited acaricide application. Such farming systems have the 
financial capacity to control cattle grazing environments to a large extent and individual 
animal movement can be restricted. Through diagnostic testing, herd composition and 
disease status can be monitored and controlled. Near complete focal eradication of ticks 
under these conditions could be achieved through vaccination using concealed tick gut 
antigens such as Ra86 in combination with controlled acaricide use. With decline in tick 
populations, incidents of tick-borne diseases are likely to decrease as seen with Bm86 based 
vaccination (de la Fuente et al., 2007). In contrast to large-scale farming systems, small-scale 
farmers have limited cash resources and control over the grazing environment of their cattle 
is problematic since they may rely on small farming units (less than two hectares) or larger, 
shared, communal grazing areas. Of primary concern for small-holder farming systems is 
reducing the deleterious effects of ECF disease. The whole-herd vaccination coverage and 
acaricide employment required for effective tick control through concealed gut antigens is not 
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necessarily feasible under these conditions. Additionally, if communal grazing is employed, 
mixing of animals of different origins, disease status and vaccination histories occurs. In 
areas such as these, reducing the severity of ECF may be successfully achieved through 
transmission-blocking vaccines. Through a substantial reduction of the sporozoite parasite 
dose received by calves, natural immunity can be developed without animals experiencing 
severe disease symptoms. This protection should extend throughout the lifetime of an animal 
if natural low-level exposure is maintained. 
The potential for tick and tick-borne disease control through anti-tick vaccination has 
been clearly demonstrated by the Bm86 based commercial products, Gavac™ and 
TickGard™ which were used widely to control R. microplus. Through the development of this 
vaccine, valuable lessons have been learned which should make second-generation anti-tick 
vaccine development more successful (Guerrero et al., 2012). Through the work performed 
within the framework of this PhD thesis and presented here, the potential of various anti-tick 
vaccine candidates were evaluated in their natural host-pathogen-vector system for their 
ability to control R. appendiculatus populations and interfere with T. parva transmission to the 
cattle host. 
Anti-tick vaccination has been studied primarily for the control of the one host tick, R. 
microplus. Substantial differences in biology between R. microplus and R. appendiculatus will 
most likely translate into modifications of anti-tick vaccine development approaches 
necessary to successfully tackle R. appendiculatus. R. microplus feeds on cattle over a 
prolonged period of time which may take up to a month. This allows a continuous binding of 
vaccine-induced host anti-tick antibodies to the tick target antigen. In contrast, R. 
appendiculatus feeds between five and seven days on cattle.  Within this relatively short time 
frame the full impact of the host immune system has to be delivered. Alternatively, targeting 
of novel anti-tick antigens with essential functions during the periods when R. appendiculatus 
ticks digest the blood meal, molt into the next instar or lay eggs could prolong the anti-tick 
effect of host antibodies. All life stages feed of R. microplus feed from the same bovine host 
GENERAL DISCUSSION AND OUTLOOK 
_________________________________________________________________________ 
!!!!
158!
and whole herd vaccination has been shown to be effective for Bm86 (de la Fuente et al., 
2007). In contrast, with the three-host life cycle of R. appendiculatus, a single tick may feed 
on up to three separate cattle during its lifetime.  In cases where all animals in the herd are 
vaccinated, maximum anti-tick effect is still obtained. However, if the immature stages feed on 
non-vaccinated cattle or alternative hosts, vaccine effects may potentially be lost.   
Vaccination of cattle with Bm86 (TickGard™) had no measurable effect on feeding of 
adult female R. appendiculatus ticks (de Vos et al., 2001; Odongo et al., 2007). Inoculation of 
mice with synthetic peptides derived from the R. decoloratus homologue of Bm86, Bd86, 
induced antibodies binding to midgut sections of R. appendiculatus and R. microplus  (Kopp 
et al., 2009).  This clearly shows that certain epitopes are at least conformationally shared 
between the Bm86 homologs in these tick species. After vaccination of rabbits with 
baculovirus produced Ra86 (variants Ra85A and Ra92A), reduction of engorgement weight 
and egg production of adult female R. appendiculatus ticks was observed (Siamo et al., 
2011). These effects resembled the Bm86 vaccination induced effects against R. microplus 
(Willadsen, 2004; de la Fuente et al., 2007). No effect on engorgement weights of either larval 
or nymphal populations of R. appendiculatus was observed (Siamo et al., 2011). However, 
after vaccination of cattle with baculovirus produced Ra86 (variants Ra85A and Ra92A), the 
Ra86 induced effect in rabbits was not reproducible (Olds et al., 2012 Chapter 3). Female 
adult tick engorgement weight and reproductive capacity was not affected by Ra86 
vaccination of cattle. Surprisingly, a significantly higher proportion of nymphal ticks failed to 
molt to the adult stage after feeding from calves vaccinated with Ra86. This effect has 
important implications for the transmission of T. parva and ECF severity. Modeling 
experiments confirmed that through nymphal tick population reduction a general decrease in 
the R. appendiculatus tick population would occur over time. The transmission of T. parva by 
adult ticks has been generally associated with more severe ECF compared to nymphal 
transmission due to the higher parasite loads in adult tick salivary glands (Norval et al., 1992; 
Ochanda et al., 1996).  Removal of nymphal ticks before molting to the adult stage will result 
in lowering of the overall ECF disease burden. Additionally, in this experiment, Ra86 
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vaccination reduced T. parva infection levels in nymphal ticks that did successfully molt into 
adult ticks. Currently, we hypothesize that improvements in recombinant Ra86 vaccine 
production and formulation will result in a more substantial negative impact on R. 
appendiculatus tick populations.   
In summary, these results showed that vaccination with tick gut antigen homologs of 
Bm86 show potential for R. appendiculatus control. Recombinant Ra86 vaccination could 
serve as a component of successful tick population control and may also form a useful part of 
an ECF transmission-blocking vaccine. The use of Bm86 gut homologues for tick-borne 
disease control is underscored by a recent report by Jeyabel et al., 2010. Vaccination of cattle 
with Haa86, the Bm86 homologue from Hyalomma anatolicum anatolicum reduced the 
transmission of Theileria annulata from infected ticks to naïve cattle and an overall lower 
mortality rate was observed in vaccinated calves (Jeyabal et al., 2010).   
Parasite transmission blocking as a method of ECF control can occur at two points within 
the T. parva parasite life cycle, either from an infected cattle host to the tick vector or from an 
infected tick vector to a susceptible cattle host. To evaluate vaccines designed to interfere 
with parasite transmission and/or development within the cattle or tick hosts, experiments 
should be performed in the natural host – tick system  (Wikel, 1999). Currently, the widely 
used method for experimental infection of cattle with T. parva is through needle administration 
of high numbers of cryopreserved sporozoites (Di Giulio et al., 2012). This clearly does not 
reflect the situation in the field where sporozoites are injected together with saliva over a 
period of several days into the cattle host (Konnai et al., 2007).  
Here we evaluated a novel tick line, RAM-L, for its ability to serve as an experimental 
tool for reproducibly delivering sporozoites to susceptible calves. The aim of this experiment 
was to develop a cattle – tick – pathogen system mimicking natural infection that takes place 
under field situations. This model should serve as an evaluation tool for novel candidates at 
an early stage of vaccine development. In Chapter 4, we demonstrate that the RAM-L line is 
GENERAL DISCUSSION AND OUTLOOK 
_________________________________________________________________________ 
!!!!
160!
able to deliver sporozoites to all calves exposed to RAM-L tick challenge. RAM-L closely 
resembles ticks collected from areas where T. parva is endemically stable in the terms of 
infection levels and distribution within the RAM-L population. Interestingly, tick-mediated 
sporozoite delivery induced a fully protective immune response in cattle against lethal 
sporozoite needle challenge. To our knowledge, this is the first autologous tick – cattle 
infection model that enables novel and essential investigations into T. parva biology, tick – 
pathogen interaction and dissection of immune response against tick-borne diseases of cattle 
in the field. The strategies developed here can be extrapolated to study other cattle tick-borne 
diseases including babesiosis and anaplasmosis.  
Next, using this RAM-L line, a multivalent transmission blocking vaccine designed to 
inhibit T. parva transmission from an infected tick vector to susceptible cattle was evaluated 
(Chapter 5). This vaccine contained several recombinant tick antigens in conjunction with a 
single parasite sporozoite component aimed to inhibit parasite entry into the bovine vascular 
system and lymphoid cells, respectively. In comparison to the control group, vaccination 
increased the number of animals undergoing primary T. parva infection without developing 
any (non-responder) or only mild clinical symptoms of ECF (mild-reactors). Mild reactions 
were characterized by the presence of a low-grade fever and no detectable sporozoite or 
piroplasm parasites while non-reactors showed no symptoms of infection. Importantly, these 
non-responder and mild-reactor calves fully withstood a subsequent lethal homologous 
needle-based sporozoite challenge. Hence, this multivalent vaccination reduced clinical ECF 
symptoms while at the same time allowed the establishment of a protective immune response 
through the very low levels of sporozoites injected. We show here that transmission-blocking 
vaccination for the control of ECF is feasible and, of paramount importance, that this 
vaccination does not prevent the development of protective ECF immunity. Clearly, the 
efficacy of the multivalent transmission-blocking vaccine described in chapter 5 has to be 
improved, possibly through novel vaccine formulations and/or better selection of vaccine 
candidates. The development of potential transmission-blocking vaccines interfering with T. 
parva macrogamete and zygote binding/invasion of tick gut cells has not been evaluated for 
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T. parva. The molecular mechanisms involved in sexual recombination and gut 
binding/invasion are essentially unknown and further research in basic parasite biology is 
fundamental. A similar vaccine approach has been shown to be viable for preventing Lyme 
disease transmission and in our opinion warrants further investigation for T. parva. 
Identification of new targets for effective R. appendiculatus and ECF vaccination-based 
control is essential.  This will require in-depth investigations studying tick biology at genomic, 
regulatory and proteomic levels. Although a complete R. appendiculatus genome is not 
available, substantial gene sequences are already known. A better understanding of the 
molecular mechanisms governing T. parva sporozoite entry into bovine cells will support 
selection of suitable candidates.  With advances in genome sequence analysis (Patel et al., 
2012, manuscript submitted), this resource for T. parva candidate selection is being actively 
pursued. A multi-stage, multi-pathogen vaccine incorporating essential and conserved 
antigens from both R. appendiculatus and T. parva might provide the best option for an 
efficient sub-unit vaccine approach. 
As seen with Ra86, recombinant tick antigen production and correct folding of 
conformational epitopes can be difficult. Additionally, there is no easy way to evaluate these 
recombinant antigens for preservation of natural protein conformation present within the tick. 
Recently published papers describing a novel method of bacterial membrane bound Bm95 
and Bm86 production may be useful for the production of Ra86 (Canales et al., 2008; 
Canales et al., 2009; Almazán et al., 2012).  It is well known that the antigenic epitopes 
recognized by different vaccinated vertebrate host species may not necessarily overlap, 
resulting in different anti-tick effects when testing an identical product in various host species. 
None of the antigens evaluated in our study have been previously investigated in the 
autologous cattle - R. appendiculatus - T. parva system. The results obtained here differ from 
previous reports testing these antigens in mice, rabbits or guinea pigs. With the novel, defined 
tick challenge model based on RAM-L, future anti-tick vaccine evaluation under field-like 
conditions is now possible.  In summary, this work shows that anti-tick vaccination has strong 
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potential to play a key role in novel, integrated control strategies for T. parva and its vector, R. 
appendiculatus. 
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